<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">54090</article-id><article-id pub-id-type="doi">10.7554/eLife.54090</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>Bmal1 integrates mitochondrial metabolism and macrophage activation</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-168871"><name><surname>Alexander</surname><given-names>Ryan K</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9204-9586</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-168872"><name><surname>Liou</surname><given-names>Yae-Huei</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-184682"><name><surname>Knudsen</surname><given-names>Nelson H</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-168874"><name><surname>Starost</surname><given-names>Kyle A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-168875"><name><surname>Xu</surname><given-names>Chuanrui</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-3225-4083</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-168876"><name><surname>Hyde</surname><given-names>Alexander L</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-168877"><name><surname>Liu</surname><given-names>Sihao</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/><xref ref-type="fn" rid="pa1">†</xref></contrib><contrib contrib-type="author" id="author-168878"><name><surname>Jacobi</surname><given-names>David</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/><xref ref-type="fn" rid="pa2">‡</xref></contrib><contrib contrib-type="author" id="author-168879"><name><surname>Liao</surname><given-names>Nan-Shih</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-35993"><name><surname>Lee</surname><given-names>Chih-Hao</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6090-0786</contrib-id><email>clee@hsph.harvard.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund8"/><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Department of Molecular Metabolism, Division of Biological Sciences, Harvard TH Chan School of Public Health</institution><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution>School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology</institution><addr-line><named-content content-type="city">Wuhan</named-content></addr-line><country>China</country></aff><aff id="aff3"><label>3</label><institution>Institute of Molecular Biology, Academia Sinica</institution><addr-line><named-content content-type="city">Taiwanese</named-content></addr-line><country>China</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Rothlin</surname><given-names>Carla V</given-names></name><role>Reviewing Editor</role><aff><institution>Yale School of Medicine</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Rath</surname><given-names>Satyajit</given-names></name><role>Senior Editor</role><aff><institution>Indian Institute of Science Education and Research (IISER)</institution><country>India</country></aff></contrib></contrib-group><author-notes><fn fn-type="present-address" id="pa1"><label>†</label><p>Ionis Pharmaceuticals, Carlsbad, United States</p></fn><fn fn-type="present-address" id="pa2"><label>‡</label><p>l'institut du thorax, INSERM, CNRS, UNIV Nantes &amp; CHU Nantes, Nantes, France</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>12</day><month>05</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>9</volume><elocation-id>e54090</elocation-id><history><date date-type="received" iso-8601-date="2019-12-02"><day>02</day><month>12</month><year>2019</year></date><date date-type="accepted" iso-8601-date="2020-05-11"><day>11</day><month>05</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, Alexander et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Alexander et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-54090-v2.pdf"/><abstract><p>Metabolic pathways and inflammatory processes are under circadian regulation. Rhythmic immune cell recruitment is known to impact infection outcomes, but whether the circadian clock modulates immunometabolism remains unclear. We find that the molecular clock Bmal1 is induced by inflammatory stimulants, including Ifn-γ/lipopolysaccharide (M1) and tumor-conditioned medium, to maintain mitochondrial metabolism under metabolically stressed conditions in mouse macrophages. Upon M1 stimulation, myeloid-specific <italic>Bmal1</italic> knockout (M-BKO) renders macrophages unable to sustain mitochondrial function, enhancing succinate dehydrogenase (SDH)-mediated mitochondrial production of reactive oxygen species as well as Hif-1α-dependent metabolic reprogramming and inflammatory damage. In tumor-associated macrophages, aberrant Hif-1α activation and metabolic dysregulation by M-BKO contribute to an immunosuppressive tumor microenvironment. Consequently, M-BKO increases melanoma tumor burden, whereas administering the SDH inhibitor dimethyl malonate suppresses tumor growth. Therefore, Bmal1 functions as a metabolic checkpoint that integrates macrophage mitochondrial metabolism, redox homeostasis and effector functions. This Bmal1-Hif-1α regulatory loop may provide therapeutic opportunities for inflammatory diseases and immunotherapy.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>macrophage</kwd><kwd>energy metabolism</kwd><kwd>anti-tumor activity</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000060</institution-id><institution>National Institute of Allergy and Infectious Diseases</institution></institution-wrap></funding-source><award-id>R21AI131659</award-id><principal-award-recipient><name><surname>Lee</surname><given-names>Chih-Hao</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000057</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>F31GM117854</award-id><principal-award-recipient><name><surname>Alexander</surname><given-names>Ryan K</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000062</institution-id><institution>National Institute of Diabetes and Digestive and Kidney Diseases</institution></institution-wrap></funding-source><award-id>F31DK107256</award-id><principal-award-recipient><name><surname>Knudsen</surname><given-names>Nelson H</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004663</institution-id><institution>Ministry of Science and Technology of Taiwan</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Liou</surname><given-names>Yae-Huei</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001869</institution-id><institution>Academia Sinica</institution></institution-wrap></funding-source><award-id>AS-106-TP-L08</award-id><principal-award-recipient><name><surname>Liao</surname><given-names>Nan-Shih</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000968</institution-id><institution>American Heart Association</institution></institution-wrap></funding-source><award-id>16GRNT31460005</award-id><principal-award-recipient><name><surname>Lee</surname><given-names>Chih-Hao</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000062</institution-id><institution>National Institute of Diabetes and Digestive and Kidney Diseases</institution></institution-wrap></funding-source><award-id>R01DK113791</award-id><principal-award-recipient><name><surname>Lee</surname><given-names>Chih-Hao</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000062</institution-id><institution>National Institute of Diabetes and Digestive and Kidney Diseases</institution></institution-wrap></funding-source><award-id>R01DK064750</award-id><principal-award-recipient><name><surname>Lee</surname><given-names>Chih-Hao</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Macrophage Bmal1 controls the timing of the glycolytic to oxidative metabolism transition that dictates the extent of Hif-1a activation and the associated inflammatory response.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Inflammation and host defense are energetically costly processes that must balance the use of host resources with an efficient containment of infection or injury. This is underpinned by the dynamic regulation of energy metabolism in immune cells in response to extrinsic signals, including cytokines, pathogen- and damage-associated molecular patterns, and tumor-derived metabolites (<xref ref-type="bibr" rid="bib1">Andrejeva and Rathmell, 2017</xref>; <xref ref-type="bibr" rid="bib4">Buck et al., 2017</xref>; <xref ref-type="bibr" rid="bib15">Ganeshan and Chawla, 2014</xref>; <xref ref-type="bibr" rid="bib19">Hotamisligil, 2017</xref>; <xref ref-type="bibr" rid="bib37">O'Neill et al., 2016</xref>). For instance, activation of macrophages by bacterial products, such as lipopolysaccharide (LPS) from gram-negative bacteria, shifts core metabolic function towards increased reliance on aerobic glycolysis, with concomitant inhibition of mitochondrial respiration (<xref ref-type="bibr" rid="bib14">Fukuzumi et al., 1996</xref>; <xref ref-type="bibr" rid="bib43">Rodríguez-Prados et al., 2010</xref>; <xref ref-type="bibr" rid="bib50">Tannahill et al., 2013</xref>). This depressed mitochondrial function appears to be by design, as this process serves multiple purposes. It leads to the so-called ‘broken TCA cycle’ that results, in part, from the shunting of citric acid to lipid synthesis (<xref ref-type="bibr" rid="bib1">Andrejeva and Rathmell, 2017</xref>). Itaconate, also derived from citrate/aconitate, can modulate macrophage immune response through different mechanisms (<xref ref-type="bibr" rid="bib26">Lampropoulou et al., 2016</xref>; <xref ref-type="bibr" rid="bib34">Mills et al., 2018</xref>). By contrast, succinate accumulates through anaplerotic reactions, notably glutaminolysis (<xref ref-type="bibr" rid="bib50">Tannahill et al., 2013</xref>). Succinate oxidation to fumarate, mediated by succinate dehydrogenase (SDH)/ETC complex II activity, is a primary source of mitochondrial reactive oxygen species (mROS) in inflammatory macrophages that are involved in bactericidal activity (<xref ref-type="bibr" rid="bib33">Mills et al., 2016</xref>; <xref ref-type="bibr" rid="bib54">West et al., 2011</xref>). Succinate/SDH is believed to trigger mROS production through accumulation of reduced coenzyme Q leading to reverse electron transfer to ETC complex I (<xref ref-type="bibr" rid="bib6">Chouchani et al., 2014</xref>; <xref ref-type="bibr" rid="bib42">Robb et al., 2018</xref>). These findings demonstrate a well-orchestrated metabolic signaling event that occurs at the expense of reduced fuel economy and compromised mitochondrial function in macrophages.</p><p>In addition to their bacteria-killing effect, mROS stabilize hypoxia-inducible factor (Hif)-1α through inhibition of prolyl-hydroxylase enzymes that target Hif-1α for ubiquitination by the von Hippel–Lindau (Vhl) E3 ubiquitin ligase and subsequent proteasomal degradation (<xref ref-type="bibr" rid="bib3">Bell et al., 2007</xref>; <xref ref-type="bibr" rid="bib21">Jaakkola et al., 2001</xref>). Hif-1α is a master transcriptional regulator of genes involved in glycolysis and anabolic metabolism, thereby supplementing the energetic needs of the broken TCA cycle (<xref ref-type="bibr" rid="bib9">Cramer et al., 2003</xref>; <xref ref-type="bibr" rid="bib32">Masson and Ratcliffe, 2014</xref>; <xref ref-type="bibr" rid="bib45">Semenza et al., 1994</xref>). Hif-1α is also required for the expression of the urea cycle enzyme arginase-1 (<italic>Arg1</italic>). Arg1 and nitric oxide synthase 2 were initially designated as markers for M2 and M1 macrophages, as these two enzymes convert the amino acid arginine to citrulline and nitric oxide, respectively. However, M1 activation also upregulates <italic>Arg1</italic> through Hif-1α. Similarly, in the nutrient-deprived tumor microenvironment, tumor-derived lactate has been proposed to increase Hif-1α activity in tumor-associated macrophages (TAMs) and thus to upregulate <italic>Arg1</italic> (<xref ref-type="bibr" rid="bib8">Colegio et al., 2014</xref>). Aberrant expression of Arg1 in TAMs results in local arginine depletion that inhibits antitumor immunity mediated by cytotoxic T cells and natural killer (NK) cells (<xref ref-type="bibr" rid="bib12">Doedens et al., 2010</xref>; <xref ref-type="bibr" rid="bib48">Steggerda et al., 2017</xref>). Accordingly, myeloid-specific deletion of <italic>Hif1a</italic> or <italic>Arg1</italic> suppresses tumor growth in mice (<xref ref-type="bibr" rid="bib8">Colegio et al., 2014</xref>; <xref ref-type="bibr" rid="bib12">Doedens et al., 2010</xref>). These observations suggest that the distinction between M1 and M2 activation may not be as clear in vivo and highlight the importance of energetic regulation in immune cell activation.</p><p>The circadian rhythm has been implicated in many biological and pathological processes, including the immune response and tumor progression (<xref ref-type="bibr" rid="bib18">Hardin and Panda, 2013</xref>; <xref ref-type="bibr" rid="bib35">Nguyen et al., 2013</xref>; <xref ref-type="bibr" rid="bib39">Papagiannakopoulos et al., 2016</xref>). The molecular clock includes the master regulator Bmal1 (or Aryl hydrocarbon receptor nuclear translocator-like protein 1, Arntl) and its transcriptional partner Clock, as well as the negative regulatory loop that includes Nr1d1, Nr1d2, period (Per1/2/3) and cryptochrome (Cry1/2) proteins, and the positive regulator loop that includes Rorα/β/γ (<xref ref-type="bibr" rid="bib18">Hardin and Panda, 2013</xref>). Several nuclear receptors, such as the peroxisome proliferator-activated receptors, Pparα, Pparδ/β and Pparγ, are downstream of Bmal1/Clock and control the expression of clock output genes (<xref ref-type="bibr" rid="bib5">Canaple et al., 2006</xref>; <xref ref-type="bibr" rid="bib29">Liu et al., 2013</xref>; <xref ref-type="bibr" rid="bib57">Yang et al., 2006</xref>). The circadian clock is both robust and flexible. It has been demonstrated that time-restricted feeding in mice can synchronize the peripheral clock separately from the central clock (<xref ref-type="bibr" rid="bib11">Damiola et al., 2000</xref>), suggesting that a primary function of circadian rhythm is to maximize metabolic efficiency. In concert, we and others have shown that hepatic Bmal1 regulates rhythmic mitochondrial capacity in anticipation of nutrient availability (<xref ref-type="bibr" rid="bib22">Jacobi et al., 2015</xref>; <xref ref-type="bibr" rid="bib40">Peek et al., 2013</xref>). Prior studies have implicated the circadian oscillator in regulating macrophage inflammatory function. Notably, myeloid-specific <italic>Bmal1</italic> deletion disrupts diurnal monocyte trafficking and increases systemic inflammation and mortality in sepsis mouse models (<xref ref-type="bibr" rid="bib35">Nguyen et al., 2013</xref>). Whether and how the circadian clock controls the metabolism of immune cells to modulate their effector functions remains unclear.</p><p>In the present study, we describe a cell-autonomous role for Bmal1 in macrophage energetic regulation. Bmal1 is induced following macrophage inflammatory stimulation. Its loss-of-function exacerbates mitochondrial dysfunction, energetic stress and Hif-1α-dependent metabolic reprogramming. By using the B16-F10 melanoma model, we obtained results that demonstrate that the regulatory axis between Bmal1 and Hif-1α dictates macrophage energy investment that is relevant for discrete activation or polarization states, including activation of M1 and tumor-associated macrophages.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>The circadian clock is a transcriptional module induced by M1 activation</title><p>To assess transcriptional regulators that modulate the energetics and inflammatory function of macrophages, we performed RNA sequencing (RNA-seq) comparing interferon-γ (Ifn-γ) primed bone-marrow-derived macrophages (BMDM) without or with LPS stimulation (10 ng/mL for 8 hr, referred to as M1 activation). Gene ontology analysis using the DAVID platform was performed to identify clusters of transcription factors that were up- or downregulated in inflammatory macrophages, which were used to generate a protein–protein interaction map using STRING (<xref ref-type="table" rid="table1">Table 1</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). Several activators of mitochondrial function or biogenesis were repressed, including <italic>Myc</italic> (<xref ref-type="bibr" rid="bib28">Li et al., 2005</xref>), <italic>Pparg</italic>, Pparg co-activator 1 beta (<italic>Ppargc1b</italic>), and the mitochondrial transcription factor B1 (<italic>Tfb1m</italic>) and <italic>Tfb2m</italic>. On the other hand, the canonical inflammatory (e.g., <italic>Nfkb1</italic>/<italic>2</italic>, <italic>Rela</italic>/<italic>b</italic>, <italic>Hif1a</italic>, interferon regulatory factor 7 (<italic>Irf7</italic>) and <italic>Irf8</italic>) and stress response (e.g., <italic>Atf3</italic>, <italic>Atf6b</italic> and <italic>Nfe2l2</italic>) transcriptional modules were upregulated. Interestingly, clusters of circadian oscillator components (e.g., <italic>Per1</italic>, <italic>Cry1</italic>, <italic>Nr1d1</italic>, <italic>Nr1d2</italic> and <italic>Rora</italic>), as well as nuclear receptors downstream of the molecular clock (e.g., <italic>Ppard</italic> and its heterodimeric partner <italic>Rxra</italic>) (<xref ref-type="bibr" rid="bib29">Liu et al., 2013</xref>), were also induced.</p><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Transcriptional regulators that are differentially regulated in M1-activated macrophages.</title><p>Genes encoding transcriptional regulators that were significantly induced or repressed by 8h M1 stimulation (p&lt;0.05, false discovery rate [FDR] &lt;0.05, |F.C.| &gt;1.5) in WT bone-marrow-derived macrophages (BMDM) were identified by gene ontology analysis using the DAVID platform. F.C., fold change. Differentially regulated genes that matched the Transcription GO term in the Biological Processes GO database (accession GO:0006350) were used to generate a protein–protein interaction map using String (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). Uncharacterized zinc-finger proteins (ZFPs) were omitted from analyses by String.</p></caption><table frame="hsides" rules="groups"><tbody><tr><th colspan="8" valign="top">Induced (278 genes)</th></tr><tr><td valign="top">ADAR</td><td valign="top">CRY1</td><td valign="top">GTF2A1</td><td valign="top">KDM4B</td><td valign="top">MNT</td><td valign="top">PPP1R10</td><td valign="top">Snapc1</td><td valign="top">Zkscan17</td></tr><tr><td valign="top">AFF1</td><td valign="top">CRY2</td><td valign="top">GTF2E2</td><td valign="top">KDM5B</td><td valign="top">MXD1</td><td valign="top">PPP1R13L</td><td valign="top">SNAPC2</td><td valign="top">ZMIZ1</td></tr><tr><td valign="top">AFF4</td><td valign="top">CSRNP1</td><td valign="top">GTF2F1</td><td valign="top">KDM5C</td><td valign="top">MXI1</td><td valign="top">PTOV1</td><td valign="top">SOX5</td><td valign="top">ZSCAN2</td></tr><tr><td valign="top">AHR</td><td valign="top">CSRNP2</td><td valign="top">HBP1</td><td valign="top">KEAP1</td><td valign="top">MYB</td><td valign="top">PTRF</td><td valign="top">SPEN</td><td valign="top">ZSCAN29</td></tr><tr><td valign="top">AKNA</td><td valign="top">DAXX</td><td valign="top">HDAC1</td><td valign="top">KLF11</td><td valign="top">NAB2</td><td valign="top">PURA</td><td valign="top">SPIC</td><td valign="top">ZXDB</td></tr><tr><td valign="top">ANP32A</td><td valign="top">DDIT3</td><td valign="top">HES1</td><td valign="top">KLF16</td><td valign="top">NACC1</td><td valign="top">RBPJ</td><td valign="top">SREBF1</td><td valign="top"/></tr><tr><td valign="top">ARHGAP22</td><td valign="top">DDX54</td><td valign="top">HES7</td><td valign="top">KLF4</td><td valign="top">NCOA5</td><td valign="top">RCOR2</td><td valign="top">SRF</td><td valign="top"/></tr><tr><td valign="top">ARID3A</td><td valign="top">DEDD2</td><td valign="top">HEXIM1</td><td valign="top">KLF7</td><td valign="top">NCOA7</td><td valign="top">REL</td><td valign="top">ST18</td><td valign="top"/></tr><tr><td valign="top">ARID5A</td><td valign="top">DNMT3A</td><td valign="top">HIC1</td><td valign="top">KLF9</td><td valign="top">NCOR2</td><td valign="top">RELA</td><td valign="top">STAT2</td><td valign="top"/></tr><tr><td valign="top">ARNT2</td><td valign="top">DPF1</td><td valign="top">HIC2</td><td valign="top">LCOR</td><td valign="top">NFAT5</td><td valign="top">RELB</td><td valign="top">STAT3</td><td valign="top"/></tr><tr><td valign="top">ASF1A</td><td valign="top">DRAP1</td><td valign="top">HIF1A</td><td valign="top">LCORL</td><td valign="top">NFE2L2</td><td valign="top">REST</td><td valign="top">STAT4</td><td valign="top"/></tr><tr><td valign="top">ATF3</td><td valign="top">E2F5</td><td valign="top">HIF3A</td><td valign="top">LHX2</td><td valign="top">NFIL3</td><td valign="top">RFX1</td><td valign="top">STAT5A</td><td valign="top"/></tr><tr><td valign="top">ATF4</td><td valign="top">E4F1</td><td valign="top">HINFP</td><td valign="top">LIN54</td><td valign="top">NFKB1</td><td valign="top">RING1</td><td valign="top">TAF1C</td><td valign="top"/></tr><tr><td valign="top">ATF6B</td><td valign="top">EAF1</td><td valign="top">HIVEP1</td><td valign="top">LITAF</td><td valign="top">NFKB2</td><td valign="top">RNF2</td><td valign="top">TAF7</td><td valign="top"/></tr><tr><td valign="top">ATXN7L3</td><td valign="top">EDF1</td><td valign="top">HIVEP2</td><td valign="top">LMO4</td><td valign="top">NFKBIZ</td><td valign="top">RORA</td><td valign="top">TAL1</td><td valign="top"/></tr><tr><td valign="top">BANP</td><td valign="top">EGR2</td><td valign="top">HIVEP3</td><td valign="top">MAF</td><td valign="top">NOTCH1</td><td valign="top">RREB1</td><td valign="top">TBL1X</td><td valign="top"/></tr><tr><td valign="top">BATF</td><td valign="top">EID3</td><td valign="top">HLX</td><td valign="top">MAFF</td><td valign="top">NPTXR</td><td valign="top">RSLCAN18</td><td valign="top">TCEB2</td><td valign="top"/></tr><tr><td valign="top">BCL3</td><td valign="top">EIF2C1</td><td valign="top">HMG20B</td><td valign="top">MAFG</td><td valign="top">NR1D1</td><td valign="top">RUNX2</td><td valign="top">TCF4</td><td valign="top"/></tr><tr><td valign="top">BCL6</td><td valign="top">ELK1</td><td valign="top">HMGA1</td><td valign="top">MAFK</td><td valign="top">NR1D2</td><td valign="top">RUNX3</td><td valign="top">TGIF1</td><td valign="top"/></tr><tr><td valign="top">BCORL1</td><td valign="top">ELL</td><td valign="top">HMGA1-RS1</td><td valign="top">MAML1</td><td valign="top">NR1H2</td><td valign="top">RUVBL2</td><td valign="top">THAP7</td><td valign="top"/></tr><tr><td valign="top">BHLHE40</td><td valign="top">ELL2</td><td valign="top">HMGN5</td><td valign="top">MAX</td><td valign="top">NR1H3</td><td valign="top">RXRA</td><td valign="top">TLE2</td><td valign="top"/></tr><tr><td valign="top">BHLHE41</td><td valign="top">ELL3</td><td valign="top">HOPX</td><td valign="top">MBD2</td><td valign="top">NR2F6</td><td valign="top">RYBP</td><td valign="top">TLE3</td><td valign="top"/></tr><tr><td valign="top">BRWD1</td><td valign="top">EPAS1</td><td valign="top">HSF4</td><td valign="top">MDFIC</td><td valign="top">NR4A1</td><td valign="top">SAFB2</td><td valign="top">TRERF1</td><td valign="top"/></tr><tr><td valign="top">BTG2</td><td valign="top">ERF</td><td valign="top">IFI205</td><td valign="top">MECP2</td><td valign="top">NR4A2</td><td valign="top">SAP130</td><td valign="top">TRIB3</td><td valign="top"/></tr><tr><td valign="top">CAMTA2</td><td valign="top">ERN1</td><td valign="top">IFT57</td><td valign="top">MED13</td><td valign="top">NR4A3</td><td valign="top">SAP30</td><td valign="top">TRRAP</td><td valign="top"/></tr><tr><td valign="top">CASZ1</td><td valign="top">ESRRA</td><td valign="top">ILF3</td><td valign="top">MED13L</td><td valign="top">PAF1</td><td valign="top">SBNO2</td><td valign="top">TSC22D4</td><td valign="top"/></tr><tr><td valign="top">CBX4</td><td valign="top">ETS1</td><td valign="top">ING2</td><td valign="top">MED15</td><td valign="top">PAX4</td><td valign="top">SCAF1</td><td valign="top">TSHZ1</td><td valign="top"/></tr><tr><td valign="top">CCDC85B</td><td valign="top">ETV3</td><td valign="top">IRF2BP1</td><td valign="top">MED25</td><td valign="top">PCGF3</td><td valign="top">SEC14L2</td><td valign="top">USP49</td><td valign="top"/></tr><tr><td valign="top">CDKN2A</td><td valign="top">FIZ1</td><td valign="top">IRF4</td><td valign="top">MED26</td><td valign="top">PCGF5</td><td valign="top">SERTAD1</td><td valign="top">VPS72</td><td valign="top"/></tr><tr><td valign="top">CEBPB</td><td valign="top">FLII</td><td valign="top">IRF7</td><td valign="top">MED28</td><td valign="top">PER1</td><td valign="top">SETD8</td><td valign="top">WHSC1L1</td><td valign="top"/></tr><tr><td valign="top">CEBPD</td><td valign="top">FOXP1</td><td valign="top">IRF8</td><td valign="top">MED31</td><td valign="top">PER2</td><td valign="top">SFPI1</td><td valign="top">ZBTB17</td><td valign="top"/></tr><tr><td valign="top">CITED4</td><td valign="top">FOXP4</td><td valign="top">JARID2</td><td valign="top">MEF2D</td><td valign="top">PHF1</td><td valign="top">SIN3B</td><td valign="top">ZBTB24</td><td valign="top"/></tr><tr><td valign="top">CREB5</td><td valign="top">GATA2</td><td valign="top">JDP2</td><td valign="top">MIER2</td><td valign="top">PHF12</td><td valign="top">SIX1</td><td valign="top">ZBTB46</td><td valign="top"/></tr><tr><td valign="top">CREBBP</td><td valign="top">GATAD2A</td><td valign="top">JMJD6</td><td valign="top">MIER3</td><td valign="top">PIAS4</td><td valign="top">SIX5</td><td valign="top">ZBTB7A</td><td valign="top"/></tr><tr><td valign="top">CREBL2</td><td valign="top">GATAD2B</td><td valign="top">JUN</td><td valign="top">MITF</td><td valign="top">PML</td><td valign="top">SLC30A9</td><td valign="top">ZBTB7B</td><td valign="top"/></tr><tr><td valign="top">CREBZF</td><td valign="top">GFI1</td><td valign="top">JUNB</td><td valign="top">MIXL1</td><td valign="top">POU2F2</td><td valign="top">SMAD3</td><td valign="top">ZEB1</td><td valign="top"/></tr><tr><td valign="top">CREM</td><td valign="top">GLIS3</td><td valign="top">JUND</td><td valign="top">MKL1</td><td valign="top">POU3F1</td><td valign="top">SMAD4</td><td valign="top">ZFHX4</td><td valign="top"/></tr><tr><td valign="top">CRTC2</td><td valign="top">GPBP1</td><td valign="top">KDM3A</td><td valign="top">MLL1</td><td valign="top">POU6F1</td><td valign="top">SMAD7</td><td valign="top">ZGPAT</td><td valign="top"/></tr><tr><td valign="top">CRTC3</td><td valign="top">GRHL1</td><td valign="top">KDM4A</td><td valign="top">MNDA</td><td valign="top">PPARD</td><td valign="top">SMYD1</td><td valign="top">ZHX2</td><td valign="top"/></tr><tr><th colspan="8" valign="top"/></tr><tr><th colspan="8" valign="top"><bold>Repressed</bold> (195 genes)</th></tr><tr><td valign="top">ACTL6A</td><td valign="top">ELK3</td><td valign="top">IRF2</td><td valign="top">NAA15</td><td valign="top">SAP18</td><td valign="top"/><td valign="top"/><td valign="top"/></tr><tr><td valign="top">AHRR</td><td valign="top">ELP2</td><td valign="top">ITGB3BP</td><td valign="top">NCOA1</td><td valign="top">SAP25</td><td valign="top"/><td valign="top"/><td valign="top"/></tr><tr><td valign="top">AI987944</td><td valign="top">ELP3</td><td valign="top">KDM2B</td><td valign="top">NCOA3</td><td valign="top">SETD7</td><td valign="top"/><td valign="top"/><td valign="top"/></tr><tr><td valign="top">ANG</td><td valign="top">ELP4</td><td valign="top">KLF10</td><td valign="top">NFATC1</td><td valign="top">SETDB1</td><td valign="top"/><td valign="top"/><td valign="top"/></tr><tr><td valign="top">ASCC1</td><td valign="top">ENY2</td><td valign="top">KLF13</td><td valign="top">NFATC2</td><td valign="top">SNAPC5</td><td valign="top"/><td valign="top"/><td valign="top"/></tr><tr><td valign="top">ASF1B</td><td valign="top">ERCC8</td><td valign="top">KLF2</td><td valign="top">NFIA</td><td valign="top">SP3</td><td valign="top"/><td valign="top"/><td valign="top"/></tr><tr><td valign="top">ATAD2</td><td valign="top">ESR1</td><td valign="top">KLF8</td><td valign="top">NKRF</td><td valign="top">SSBP2</td><td valign="top"/><td valign="top"/><td valign="top"/></tr><tr><td valign="top">AW146154</td><td valign="top">ETOHI1</td><td valign="top">L3MBTL2</td><td valign="top">NPAT</td><td valign="top">SSRP1</td><td valign="top"/><td valign="top"/><td valign="top"/></tr><tr><td valign="top">BCL9L</td><td valign="top">ETV1</td><td valign="top">LBH</td><td valign="top">NPM3</td><td valign="top">STAT1</td><td valign="top"/><td valign="top"/><td valign="top"/></tr><tr><td valign="top">CBFA2T3</td><td valign="top">EYA1</td><td valign="top">LRPPRC</td><td valign="top">NR2C1</td><td valign="top">SUV39H1</td><td valign="top"/><td valign="top"/><td valign="top"/></tr><tr><td valign="top">CBX3</td><td valign="top">EYA4</td><td valign="top">LYL1</td><td valign="top">NRIP1</td><td valign="top">SUV39H2</td><td valign="top"/><td valign="top"/><td valign="top"/></tr><tr><td valign="top">CBX6</td><td valign="top">EZH2</td><td valign="top">MAFB</td><td valign="top">OVOL2</td><td valign="top">SUV420H2</td><td valign="top"/><td valign="top"/><td valign="top"/></tr><tr><td valign="top">CBX8</td><td valign="top">FLI1</td><td valign="top">MARS</td><td valign="top">PA2G4</td><td valign="top">TADA1</td><td valign="top"/><td valign="top"/><td valign="top"/></tr><tr><td valign="top">CCNH</td><td valign="top">FNTB</td><td valign="top">MBTPS2</td><td valign="top">PHF19</td><td valign="top">TADA2A</td><td valign="top"/><td valign="top"/><td valign="top"/></tr><tr><td valign="top">CDCA7</td><td valign="top">FOXM1</td><td valign="top">MCM2</td><td valign="top">PHTF2</td><td valign="top">TAF4B</td><td valign="top"/><td valign="top"/><td valign="top"/></tr><tr><td valign="top">CDCA7L</td><td valign="top">GTF2H2</td><td valign="top">MCM3</td><td valign="top">PNRC2</td><td valign="top">TAF9B</td><td valign="top"/><td valign="top"/><td valign="top"/></tr><tr><td valign="top">CEBPA</td><td valign="top">GTF2I</td><td valign="top">MCM4</td><td valign="top">POLR1B</td><td valign="top">TBX6</td><td valign="top"/><td valign="top"/><td valign="top"/></tr><tr><td valign="top">CEBPG</td><td valign="top">GTF2IRD1</td><td valign="top">MCM5</td><td valign="top">POLR2G</td><td valign="top">TCEA3</td><td valign="top"/><td valign="top"/><td valign="top"/></tr><tr><td valign="top">CEBPZ</td><td valign="top">GTF3A</td><td valign="top">MCM6</td><td valign="top">POLR2I</td><td valign="top">TCEAL8</td><td valign="top"/><td valign="top"/><td valign="top"/></tr><tr><td valign="top">CHAF1A</td><td valign="top">GTF3C5</td><td valign="top">MCM7</td><td valign="top">POLR3B</td><td valign="top">TCF7L2</td><td valign="top"/><td valign="top"/><td valign="top"/></tr><tr><td valign="top">CHAF1B</td><td valign="top">HABP4</td><td valign="top">MCM8</td><td valign="top">POLR3H</td><td valign="top">TFB1M</td><td valign="top"/><td valign="top"/><td valign="top"/></tr><tr><td valign="top">CHD9</td><td valign="top">HDAC10</td><td valign="top">MCTS1</td><td valign="top">POLR3K</td><td valign="top">TFB2M</td><td valign="top"/><td valign="top"/><td valign="top"/></tr><tr><td valign="top">CHURC1</td><td valign="top">HDAC11</td><td valign="top">MED14</td><td valign="top">PPARG</td><td valign="top">TFDP2</td><td valign="top"/><td valign="top"/><td valign="top"/></tr><tr><td valign="top">CIITA</td><td valign="top">HDAC2</td><td valign="top">MED18</td><td valign="top">PPARGC1B</td><td valign="top">THOC1</td><td valign="top"/><td valign="top"/><td valign="top"/></tr><tr><td valign="top">CIR1</td><td valign="top">HDAC6</td><td valign="top">MED22</td><td valign="top">PRIM1</td><td valign="top">TLE1</td><td valign="top"/><td valign="top"/><td valign="top"/></tr><tr><td valign="top">CREB3</td><td valign="top">HDAC7</td><td valign="top">MED27</td><td valign="top">PRIM2</td><td valign="top">TRAPPC2</td><td valign="top"/><td valign="top"/><td valign="top"/></tr><tr><td valign="top">CREB3L1</td><td valign="top">HDAC8</td><td valign="top">MEF2A</td><td valign="top">PRMT7</td><td valign="top">TRIM24</td><td valign="top"/><td valign="top"/><td valign="top"/></tr><tr><td valign="top">CREB3L2</td><td valign="top">HDAC9</td><td valign="top">MEF2C</td><td valign="top">PROX2</td><td valign="top">TWISTNB</td><td valign="top"/><td valign="top"/><td valign="top"/></tr><tr><td valign="top">CTNND1</td><td valign="top">HELLS</td><td valign="top">MEIS1</td><td valign="top">PSPC1</td><td valign="top">TXNIP</td><td valign="top"/><td valign="top"/><td valign="top"/></tr><tr><td valign="top">CUX1</td><td valign="top">HHEX</td><td valign="top">MLF1IP</td><td valign="top">RAD54B</td><td valign="top">UHRF1</td><td valign="top"/><td valign="top"/><td valign="top"/></tr><tr><td valign="top">DDI2</td><td valign="top">HIP1</td><td valign="top">MLL3</td><td valign="top">RB1</td><td valign="top">USF1</td><td valign="top"/><td valign="top"/><td valign="top"/></tr><tr><td valign="top">DNMT1</td><td valign="top">HIRA</td><td valign="top">MLLT3</td><td valign="top">RBAK</td><td valign="top">VGLL4</td><td valign="top"/><td valign="top"/><td valign="top"/></tr><tr><td valign="top">DR1</td><td valign="top">HMBOX1</td><td valign="top">MNAT1</td><td valign="top">RCBTB1</td><td valign="top">VPS36</td><td valign="top"/><td valign="top"/><td valign="top"/></tr><tr><td valign="top">E2F1</td><td valign="top">HMGA2</td><td valign="top">MPV17</td><td valign="top">RCOR3</td><td valign="top">WTIP</td><td valign="top"/><td valign="top"/><td valign="top"/></tr><tr><td valign="top">E2F2</td><td valign="top">HOXA1</td><td valign="top">MXD3</td><td valign="top">RERE</td><td valign="top">ZBTB3</td><td valign="top"/><td valign="top"/><td valign="top"/></tr><tr><td valign="top">E2F6</td><td valign="top">HTATSF1</td><td valign="top">MXD4</td><td valign="top">RFC1</td><td valign="top">ZBTB8A</td><td valign="top"/><td valign="top"/><td valign="top"/></tr><tr><td valign="top">E2F7</td><td valign="top">IKBKAP</td><td valign="top">MYBL2</td><td valign="top">RPAP1</td><td valign="top">ZHX1</td><td valign="top"/><td valign="top"/><td valign="top"/></tr><tr><td valign="top">E2F8</td><td valign="top">IKZF2</td><td valign="top">MYC</td><td valign="top">RSC1A1</td><td valign="top">ZIK1</td><td valign="top"/><td valign="top"/><td valign="top"/></tr><tr><td valign="top">EGR3</td><td valign="top">IL16</td><td valign="top">MYCBP2</td><td valign="top">RSL1</td><td valign="top">ZKSCAN4</td><td valign="top"/><td valign="top"/><td valign="top"/></tr></tbody></table></table-wrap><p>We examined the expression of Bmal1, the non-redundant master regulator of circadian rhythm, and found that M1 activation (<xref ref-type="fig" rid="fig1">Figure 1A</xref>) or LPS treatment without Ifn-γ priming (<xref ref-type="fig" rid="fig1">Figure 1B</xref>) induced its mRNA and protein levels, which peaked at 12 hr after the stimulation. Because LPS was directly added to the cell culture without changing the medium, the induction of Bmal1 was not due to serum shock (<xref ref-type="bibr" rid="bib49">Tamaru et al., 2003</xref>). In fact, a one-hour LPS treatment in culture medium with 2% serum was sufficient to reset Bmal1 expression (<xref ref-type="fig" rid="fig1">Figure 1C</xref>) in a manner resembling serum shock (which requires a much higher serum concentration). Similar results were observed in mouse embryonic fibroblasts (MEFs), suggesting that the inflammatory regulation of Bmal1 was not macrophage-specific (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Macrophage Bmal1 is induced by M1 activation.</title><p>(<bold>A–C</bold>) Bmal1 protein levels (top) and relative gene expression determined by qPCR (bottom) in bone-marrow-derived macrophages (BMDM) during a 24-hr time course of M1 activation (10 ng/ml Ifn-γ overnight priming + 10 ng/ml LPS) (<bold>A</bold>), treatment with LPS alone (100 ng/ml) (<bold>B</bold>), or acute LPS treatment for 1 hr (100 ng/mL) (<bold>C</bold>). For M1- and LPS-only treatments, LPS was spiked in at time zero without medium change. For acute LPS treatment, cells were grown with LPS for one hour followed by culture in DMEM, 2% FBS without LPS (time zero indicates medium change). N = 3 biological replicates were used for qPCR. (<bold>D</bold>) Relative expression of circadian clock and inflammatory transcriptional regulators in M1-activated macrophages, as determined by qPCR. N = 3 biological replicates, statistical analysis performed using two-way ANOVA for WT vs M-BKO across the time course. Data are presented as mean ± S.E.M. *, p&lt;0.05. Experiments were repeated at least twice.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54090-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>The circadian clock is a transcriptional module that is induced by M1 activation.</title><p>(<bold>A</bold>) Annotated protein–protein interaction maps generated by STRING of transcriptional regulators that were significantly induced (left) or repressed (right) in WT macrophages by 8 hours M1 activation (Ifn-γ priming followed by stimulation with 10 ng/mL LPS) compared to time-matched controls (Ifn-γ priming without LPS), determined by RNA-seq (p&lt;0.05, FDR &lt;0.05, |F.C.|&gt;1.5). N = 3 biological replicates. F.C., fold change. See <xref ref-type="table" rid="table1">Table 1</xref> for the complete gene list. (<bold>B</bold>) Bmal1 protein levels (top panels) and relative gene expression determined by qPCR (bottom panels) in mouse embryonic fibroblasts during a 24-hr time course of M1 activation (10 ng/ml Ifn-γ overnight priming + 10 ng/ml LPS, left panels), treatment with LPS only (100 ng/ml, middle panels), or 1 hr acute LPS treatment (100 ng/mL, right panels). For M1- and LPS-only treatments, LPS was spiked in at time zero without medium change. For acute LPS treatment, cells were grown with LPS for one hour followed by culture in DMEM, 2% FBS without LPS (time zero indicates medium change). N = 3 biological replicates for qPCR. (<bold>C</bold>) Gene expression during a 24-hr time course of Il-4 treatment in WT and M-BKO macrophages determined by qPCR. N = 3 biological replicates. Data are presented as mean ± S.E.M. *, p&lt;0.05. Cell culture experiments were repeated at least twice.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54090-fig1-figsupp1-v2.tif"/></fig></fig-group><p>Myeloid-specific <italic>Bmal1</italic> knockout (M-BKO, <italic>Bmal1<sup>f/f</sup></italic> crossed to <italic>Lyz2-Cre</italic>) mice were generated to determine the role of the circadian clock in macrophage function. <italic>Bmal1<sup>f/f</sup></italic> was used as the wild-type control (WT). M-BKO did not affect M1 induction of canonical inflammatory regulators, such as <italic>Nfkb1</italic>, <italic>Stat3</italic>, <italic>Hif1a</italic> and <italic>Myc</italic> (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). The expression of genes downstream of Bmal1, including <italic>Nr1d2</italic>, <italic>Cry1</italic> and <italic>Ppard</italic>, was dysregulated, and there was a further reduction of <italic>Pparg</italic> expression by M1 activation in M-BKO macrophages compared to WT cells (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). By contrast, M2 activation by Il-4 did not regulate <italic>Bmal1</italic> mRNA levels, and Il-4-induced expression of <italic>Arg1</italic> and <italic>Mgl2</italic> was not altered by M-BKO (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>). These results suggest that the circadian clock may function as a downstream effector of M1 stimulation in a cell-autonomous manner.</p></sec><sec id="s2-2"><title>Bmal1 promotes mitochondrial metabolism in inflammatory macrophages</title><p>Because Pparδ/Pparγ are known regulators of mitochondrial function and energy substrate utilization in macrophages (<xref ref-type="bibr" rid="bib10">Dai et al., 2017</xref>; <xref ref-type="bibr" rid="bib23">Kang et al., 2008</xref>; <xref ref-type="bibr" rid="bib27">Lee et al., 2006</xref>; <xref ref-type="bibr" rid="bib38">Odegaard et al., 2007</xref>), we sought to determine the role of Bmal1 in macrophage bioenergetic control. In WT macrophages, M1 activation caused a progressive decrease in mitochondrial content, which was more pronounced in M-BKO macrophages (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). The reduced mitochondrial content was accompanied by elevated protein levels of the mitophagy receptor Bnip3 (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>). The Seahorse Mito Stress test also showed a steeper decline in oxygen consumption rate (OCR) following M1 treatment in M-BKO macrophages, compared to WT cells (<xref ref-type="fig" rid="fig2">Figure 2B</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>). Measurement of ETC complex activity in isolated mitochondria indicated that M-BKO caused a significant reduction in the activities of complexes II and III, given an equal amount of mitochondrial protein, 6 hr after M1 stimulation (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). This suggests that macrophage <italic>Bmal1</italic> gene deletion also worsened M1-mediated suppression of mitochondrial function. To determine whether M-BKO affected the basal respiration and/or the recovery of mitochondrial homeostasis following inflammatory insults, we performed Mito Stress tests 24 hr after acute serum shock or LPS treatment, both of which synchronized <italic>Bmal1</italic> gene expression (<xref ref-type="bibr" rid="bib49">Tamaru et al., 2003</xref> and <xref ref-type="fig" rid="fig1">Figure 1C</xref>). There was no genotypic difference in the OCR at the resting state, and serum shock did not affect respiration in WT and M-BKO macrophages (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C</xref>). By contrast, the basal OCR of M-BKO macrophages remained suppressed 24 hr following acute LPS treatment, whereas the basal OCR was completely recovered in WT macrophages (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D</xref>). Thus, <italic>Bmal1</italic> gene deletion impacts macrophage mitochondrial respiration both during inflammatory stimulations and during the subsequent recovery phase.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Bmal1 is required to maintain mitochondrial metabolism.</title><p>(<bold>A</bold>) Assessment of mitochondrial mass in macrophages throughout a time course of M1 activation using Mitotracker Green (mean fluorescence intensity, MFI) determined by flow cytometry. N = 3 biological replicates, statistical analysis was performed using two-way ANOVA for WT vs M-BKO across the time course. (<bold>B</bold>) Basal oxygen consumption rate (OCR) in Ifn-γ-primed macrophages pretreated without or with LPS (10 ng/mL) for 2 or 6 hr before the assay. See <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref> for the full assay results. The assay medium contained minimal DMEM with 5 mM glucose and 1 mM sodium pyruvate, pH 7.4. N = 5 biological replicates, statistical analysis was performed using two-way ANOVA for WT vs M-BKO across the time course. (<bold>C</bold>) Activities of ETC complexes in isolated mitochondria from WT and M-BKO macrophages after 6 hours M1 stimulation. N = 3 biological replicates, statistical analysis was performed using Student’s T test. (<bold>D</bold>) Extracellular flux analysis in Ifn-γ-primed macrophages measuring the changes in extracellular acidification rate (ECAR, left panel) and oxygen consumption rate (OCR, right panel) following LPS injection (100 ng/mL). The assay medium contained 5 mM glucose and 1 mM pyruvate in minimal DMEM with 2% dialyzed FBS, pH 7.4. N = 5 biological replicates, statistical analysis was performed using two-way ANOVA for WT vs M-BKO across the time course. (<bold>E</bold>) Glycolytic stress test in Ifn-γ-primed macrophages measuring ECAR following glucose (25 mM) injection, with or without LPS (100 ng/mL). Maximal glycolytic rate was determined by injection of oligomycin (OM, 2 μM), and glycolysis-dependent ECAR was determined by injection of 2-deoxyglucose (2-DG, 50 mM). The assay medium contained minimal DMEM with 2% dialyzed FBS, pH 7.4. N = 5 biological replicates, statistical analysis was performed using two-way ANOVA for WT vs M-BKO across the time course. Data are presented as mean ± S.E.M. *, p&lt;0.05. Experiments were repeated at least twice.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54090-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Effects of <italic>Bmal1</italic> gene deletion and overexpression on glycolytic versus oxidative metabolism.</title><p>(<bold>A</bold>) Immunoblot of the mitophagy regulator Bnip3 in M1-activated WT and M-BKO BMDMs. (<bold>B</bold>) Mitostress test measuring oxygen consumption rate (OCR) in Ifn-γ-primed macrophages pretreated without or with LPS (10 ng/mL) for 2 or 6 hr before the assay. Following three measurements of basal respiration, sequential injections of oligomycin (OM, 2 μM), carbonyl cyanide-4-phenylhydrazone (FCCP, 0.5, μM) and rotenone and antimycin A (rot/AA, 1 μM) were carried out to determine uncoupled respiration, spare respiratory capacity, and non-mitochondrial respiration, respectively. The assay medium contained minimal DMEM with 5 mM glucose and 1 mM sodium pyruvate, pH 7.4. N = 5 biological replicates. (<bold>C</bold>) Mitostress test measuring OCR in macrophages without (control, Ctl) or with serum shock resulting from treatment with 50% FBS for 2 hr to synchronize the circadian clock (Synchronized). Cells were recovered in fresh growth medium containing 10% FBS and the assay was performed 16 hr after the serum shock treatment. N = 5 biological replicates. (<bold>D</bold>) Mitostress test measuring OCR in macrophages without or with acute LPS treatment. Cells were cultured in growth medium with 2% FBS without (Ctl) or with 100 ng/mL LPS for 2 hr (LPS recovery), followed by recovery in fresh growth medium with 2% FBS for 24 hr prior to the assay. N = 5 biological replicates, statistical analysis was performed using two-way ANOVA for Ctl vs LPS recovery across the time course. (<bold>E</bold>) Extracellular flux analysis of thioglycollate-elicited peritoneal macrophages measuring the changes in ECAR (left panel) and OCR (right panel) following LPS injection (final concentration 1 μg/mL). The assay medium contained 5 mM glucose and 1 mM pyruvate in minimal DMEM with 2% dialyzed FBS, pH 7.4. N = 5 biological replicates, statistical analysis was performed using two-way ANOVA for WT vs M-BKO across the time course. (<bold>F</bold>) <italic>Bmal1</italic> mRNA expression determined by qPCR (left) and protein levels (right) in RAW264.7 macrophage stable lines. Bmal1-OE, Bmal1 overexpressing stable line. Cells that were transduced with empty vector were used as the control. N = 3 biological replicates for qPCR, statistical analysis was performed using Student’s T test. V, vector control; OE, Bmal1 overexpression. (<bold>G</bold>) Measurement of the changes in ECAR (left) and OCR (right) in Ifn-γ-primed RAW264.7 stable lines after injection with LPS (final concentration 100 ng/mL). The assay medium contained 25 mM glucose and 1 mM pyruvate in minimal DMEM with 2% dialyzed FBS, pH 7.4. N = 5 biological replicates, statistical analysis was performed using two-way ANOVA for control vs Bmal1 OE across the time course. (<bold>H</bold>) Blood glucose levels in 4-month-old WT and M-BKO male mice before and 6 hr after i.p. injection with 10 μg LPS per g body weight. N = 10 mice, statistical analysis was performed using Student’s T test. (<bold>I</bold>) Glycolytic stress test in splenic macrophages isolated from mice in panel (<bold>D</bold>) that were sacrificed 6 hr after LPS injection. ECAR was measured before and after injection with glucose (25 mM). Maximal glycolytic rate was determined by injection of oligomycin (OM, 2 μM). Glycolysis-dependent ECAR was determined by injection of 2-deoxyglucose (2-DG, 50 mM). The assay medium contained minimal DMEM, pH 7.4. N = 10 biological replicates, statistical analysis was performed using two-way ANOVA for WT vs M-BKO across the time course. Data are presented as mean ± S.E.M. *, p&lt;0.05. Experiments were repeated at least twice.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54090-fig2-figsupp1-v2.tif"/></fig></fig-group><p>Seahorse extracellular flux analysis showed that LPS injection increased the extracellular acidification rate (ECAR, indicative of lactic acid secretion) and decreased the oxygen consumption rate (OCR) of WT macrophages, as expected from aerobic glycolysis (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). The ECAR and OCR were further enhanced and suppressed, respectively, in M-BKO macrophages. Similar results were obtained in thioglycollate-elicited peritoneal macrophages isolated from WT and M-BKO mice (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1E</xref>). By contrast, stable overexpression of <italic>Bmal1</italic> (Bmal1-OE) in RAW264.7 macrophages resulted in higher OCR and lower ECAR after LPS stimulation, compared to control cells (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1F-G</xref>). To examine aerobic glycolysis directly, glucose was injected during the extracellular flux assay with or without co-injection of LPS. There was no difference in the basal glycolytic rate between WT and M-BKO macrophages (<xref ref-type="fig" rid="fig2">Figure 2E</xref>). LPS increased ECAR in both genotypes and to a greater extent in M-BKO macrophages. The induced ECAR could be blocked by injection of 2-deoxyglucose (2-DG), confirming that the acidification was caused by aerobic glycolysis. Furthermore, an increase in the glycolytic rate was observed in splenic macrophages from M-BKO mice isolated 6 hr after i.p. injection of LPS, which was accompanied by lowered circulating glucose levels, indicative of increased glucose consumption by inflammatory myeloid cells in M-BKO mice when compared to WT animals (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1H-I</xref>).</p><p>To further assess the metabolic state, metabolomics analyses were employed to compare the cellular metabolite levels of WT and M-BKO macrophages 0, 6 and 12 hr after M1 activation (<xref ref-type="fig" rid="fig3">Figure 3A–B</xref> and <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>). As has been reported (<xref ref-type="bibr" rid="bib50">Tannahill et al., 2013</xref>), M1 activation caused accumulation of glycolytic intermediates (glucose-6-phosphate, fructose-6-phosphate and lactic acid) and depletion of TCA metabolites (e.g. citrate) but accumulation of succinate. Glycolytic metabolites and succinate were significantly higher in M-BKO macrophages than in WT cells. M-BKO cells also showed accumulation of several amino acids and intermediates of the urea cycle (which detoxifies ammonia released from amino-acid deamination) (<xref ref-type="fig" rid="fig3">Figure 3A</xref> and <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>). Consistent with the increased glycolytic metabolites, M1-stimulated glucose uptake and lactate production were higher in M-BKO macrophages than in WT cells (<xref ref-type="fig" rid="fig3">Figure 3C–D</xref>). These results suggest that <italic>Bmal1</italic> loss-of-function leads to metabolic dysregulation in M1-stimulated macrophages.</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title><italic>Bmal1</italic> deletion induces a metabolic shift for glycolytic and amino-acid metabolism.</title><p>(<bold>A</bold>) Summary of steady-state metabolomics data for differentially regulated metabolites from WT and M-BKO macrophages throughout a 12-hour M1 activation time course. Data are presented as heat maps (normalized to WT control for each metabolite, each panel is the average of four biological replicates). Statistical analysis was performed using two-way ANOVA for WT vs M-BKO across the time course. (<bold>B</bold>) Box plots of the relative abundances of select metabolites in panel (<bold>A</bold>). (<bold>C</bold>, <bold>D</bold>) Uptake of [<sup>3</sup>H]−2-deoxyglucose (C) and lactate secretion (D) in control or M1-activated macrophages. N = 3 biological replicates, statistical analysis was performed using Student’s T test. Cell culture assays were repeated at least twice.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Metabolomics data for M1-activated WT and M-BKO macrophages.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-54090-fig3-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54090-fig3-v2.tif"/></fig></sec><sec id="s2-3"><title>Bmal1–Hif-1α crosstalk regulates macrophage energy metabolism</title><p>As mentioned earlier, Hif-1α is a primary regulator of glucose metabolism in inflammatory macrophages. The enhanced aerobic glycolysis in M-BKO macrophages prompted us to examine whether Hif-1α activity was aberrantly elevated in these cells. Western blot analyses revealed that M1 activation led to a several-fold induction of Hif-1α protein levels in M-BKO macrophages compared to WT cells (<xref ref-type="fig" rid="fig4">Figure 4A</xref>), whereas Bmal1-OE RAW264.7 macrophages showed reduced Hif-1α protein (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>). The expression of Hif-1α targets, such as lactate dehydrogenase A (<italic>Ldha</italic>), <italic>Arg1</italic> and <italic>Il1b</italic>, was enhanced by M-BKO and blocked by myeloid <italic>Hif1a</italic> knockout (M-HKO, <xref ref-type="fig" rid="fig4">Figure 4B</xref>). Hif-1α gene expression did not differ between WT and M-BKO cells (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). mROS derived from increased succinate oxidation has previously been demonstrated to stabilize Hif-1α protein in inflammatory macrophages (<xref ref-type="bibr" rid="bib33">Mills et al., 2016</xref>). Metabolite analyses showed accumulation of succinate in M-BKO macrophages, suggesting that elevated mROS may be the cause of the increased Hif-1α protein. In fact, levels of mROS were higher in isolated mitochondria from M-BKO macrophages at 1 hr and 4 hr of M1 activation than in WT macrophages (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). The addition of succinate increased mROS production in mitochondria from both WT and M-BKO macrophages. An additional two-fold induction of mROS was detected in mitochondria from 4-hr M1-stimulated M-BKO, but not in those from WT macrophages. Hif-1α protein accumulation could be normalized between genotypes by co-treatment with the antioxidant N-acetylcysteine (N-AC) or the competitive complex II inhibitor dimethylmalonate (DMM), which blocks mROS production (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). Furthermore, M1-stimulated glucose uptake, lactate release and aerobic glycolysis were attenuated in myeloid-specific <italic>Bmal1</italic> and <italic>Hif1a</italic> double knockout macrophages (M-BHdKO; <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B-D</xref>), indicating that the increased glucose utilization in M-BKO was Hif-1α-dependent.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title><italic>Bmal1</italic> loss-of-function increases oxidative stress and Hif-1α protein accumulation.</title><p>(<bold>A</bold>) Immunoblots of Hif-1α and Bmal1 protein levels in WT and M-BKO macrophages during a 24-hr time course of M1 activation. (<bold>B</bold>) Relative expression of Hif-1α target genes in WT, M-BKO and M-HKO macrophages determined by qPCR. N = 3 biological replicates, statistical analysis was performed using two-way ANOVA for WT vs M-BKO or WT vs M-HKO across the time course. (<bold>C</bold>) Measurement of mROS using MitoSox Red (mean fluorescence intensity, MFI) in mitochondria isolated from control or M1-activated macrophages. Succinate (Suc, 10 mM) was included during MitoSox Red staining where indicated. N = 3 biological replicates, statistical analysis was performed using two-way ANOVA for WT vs M-BKO across the time course. (<bold>D</bold>) Hif-1α protein levels in control or 8-hr M1-activated macrophages co-treated with or without N-acetylcysteine (NAC) or 10 mM dimethylmalonate (DMM). Data are presented as mean ± S.E.M. *, p&lt;0.05 for WT vs M-BKO and p&lt;0.05 for WT vs M-HKO. Experiments were repeated at least twice.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54090-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Increased oxidative stress and Hif-1α activity in M1 activated M-BKO macrophages.</title><p>(<bold>A</bold>) Hif-1α protein levels in M1-activated (primed with 10 ng/mL Ifn-γ and stimulated with 50 ng/mL LPS) control and Bmal1-OE RAW264.7 stable lines. (<bold>B, C</bold>) Uptake of [<sup>3</sup>H]−2-deoxyglucose and lactate secretion in control or M1-activated macrophages. N = 3 biological replicates, statistical analysis was performed using Student’s T test. M-BHdko: myeloid-specific <italic>Bmal1</italic> and <italic>Hif1a</italic> double knockout. (<bold>D</bold>) Glycolytic stress test in Ifn-γ-primed macrophages measuring ECAR following glucose (25 mM) injection without or with LPS (100 ng/mL). Maximal glycolytic rate was determined by injection of oligomycin (OM, 2 μM), and glycolysis-dependent ECAR was determined by injection of 2-deoxyglucose (2-DG, 50 mM). The assay medium contained minimal DMEM with 2% dialyzed FBS, pH 7.4. N = 5 biological replicates. The difference between LPS-treated WT and M-BHdKO macrophages was determined by two-way ANOVA across the time course. (<bold>E</bold>) Expression of Nrf2 target genes determined by qPCR throughout a 24-hr time course following M1 stimulation. N = 3 biological replicates, statistical analysis was performed using two-way ANOVA for WT vs M-BKO across the time course. Data are presented as mean ± S.E.M. *, p&lt;0.05. Experiments were repeated at least twice.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54090-fig4-figsupp1-v2.tif"/></fig></fig-group><p>A previous study suggests that <italic>Bmal1</italic> deletion impairs the expression of <italic>Nfe2l2</italic> (which encodes Nrf2) and its downstream antioxidant genes, thereby increasing oxidative stress (<xref ref-type="bibr" rid="bib13">Early et al., 2018</xref>). However, we found that expression of <italic>Nfe2l2-</italic> and Nrf2-induced oxidative stress responsive genes, such as NAD(P)H quinone dehydrogenase 1 (<italic>Nqo1</italic>; <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1E</xref>), were upregulated in M-BKO macrophages upon M1 stimulation, suggesting that increased mROS associated with M-BKO was the cause rather than the consequence of dysregulated Nrf2 signaling. Collectively, these data indicate that Bmal1 and Hif-1α regulate opposing metabolic programs and that Bmal1-mediated mitochondrial metabolism serves to fine-tune Hif-1α activity by modulating oxidative stress.</p></sec><sec id="s2-4"><title><italic>Bmal1</italic> loss-of-function induces metabolic reprogramming toward amino-acid catabolism</title><p>To characterize fully metabolic programs that were impacted by <italic>Bmal1</italic> loss of function, we compared RNA-seq data from control and M1-activated WT and M-BKO macrophages. These analyses revealed that the majority of M1-induced or -suppressed genes were regulated in a similar manner in WT and M-BKO macrophages, suggesting that <italic>Bmal1</italic> gene deletion affected specific inflammatory processes (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref> and <xref ref-type="supplementary-material" rid="fig5sdata1">Figure 5—source data 1</xref>) and in line with the intact expression pattern of Nfkb1 in M-BKO macrophages (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). Gene ontology analyses indicated that the most enriched categories of M1-upregulated genes shared by both genotypes included regulation of apoptosis, response to stress and cytokine production. Among the top categories of suppressed genes were the cell cycle, DNA repair and carbohydrate metabolism. In the carbohydrate metabolism category, most TCA cycle enzymes were downregulated by M1 activation (<xref ref-type="fig" rid="fig5">Figure 5A</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Genes involved in amino-acid uptake and catabolism are upregulated in M-BKO macrophages.</title><p>(<bold>A</bold>) Schematic representation of M1-regulated genes involved in amino-acid and TCA metabolism determined by RNA-seq. Genes in blue are downregulated whereas genes in red are upregulated by 8 hours M1 activation in both WT and M-BKO macrophages. Genes that are differentially regulated in these two genotypes are displayed in heat maps on the right. F.C., fold change. N = 3 biological replicates. BCAAs, branch chain amino acids; Keto AAs, ketogenic amino acids; Cic, mitochondrial citrate carrier. (<bold>B</bold>) Relative expression of differentially regulated genes identified by RNA-seq and validated by qPCR in a 24-hr time course of M1 activation. N = 3 biological replicates, statistical analysis was performed using two-way ANOVA for WT vs M-BKO across the time course. (<bold>C</bold>) Hif-1α protein levels in control or 6-hr M1-activated macrophages with or without co-treatment of the neutral amino-acid transport inhibitor 2-amino-2-norbornanecarboxylic acid (BCH, 10 mM). (<bold>D</bold>) Gene expression in control or 6-hr M1-activated macrophages with or without co-treatment of 10 mM BCH and/or the complex II inhibitor dimethyl malonate (DMM, 10 mM) determined by qPCR. N = 3 biological replicates, statistical analysis was performed using Student’s T test. Data are presented as mean ± S.E.M. *, p&lt;0.05. Cell culture experiments were repeated at least twice.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Functional annotation clustering genes commonly and differentially regulated between WT and M-BKO BMDMs by 8 h M1 activation.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-54090-fig5-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54090-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Transcriptome analysis of genes that are regulated by M1 stimulation in WT and M-BKO macrophages.</title><p>(<bold>A</bold>) Functional annotation clustering by biological process and Venn diagram of genes identified by RNA-seq that are mutually induced (2379 genes, left) or suppressed (2644 genes, right) by 8-h M1 activation in WT and M-BKO macrophages. N = 3 biological replicates. F.C., fold change. (<bold>B</bold>) Enriched biological processes associated with genes that are differentially expressed in M1-activated WT and M-BKO macrophages. (<bold>C</bold>) Relative expression of the neutral amino-acid transporter <italic>Slc7a8</italic> (<italic>Lat2</italic>) in WT and myeloid <italic>Hif1a</italic> knockout (M-HKO) macrophages as determined by qPCR. WT samples were from <xref ref-type="fig" rid="fig5">Figure 5B</xref>. N = 3 biological replicates, statistical analysis was performed using two-way ANOVA for WT vs M-HKO across the time course. (<bold>D</bold>) Determination of glutamine utilization by extracellular flux analysis. OCR was measured before and after LPS injection (final concentration 1 μg/mL), and the assay medium contained 5 mM glutamine in minimal DMEM with 2% dialyzed FBS, pH 7.4. N = 5 biological replicates, statistical analysis was performed using two-way ANOVA for WT vs M-BKO and for WT or M-BKO vs M-BKO cells co-treated with the neutral amino-acid transport inhibitor 2-amino-2-norbornanecarboxylic acid (BCH, 10 mM) across the time course. Data are presented as mean ± S.E.M. *, p&lt;0.05. Cell culture experiments were repeated at least twice.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54090-fig5-figsupp1-v2.tif"/></fig></fig-group><p>Direct comparison between M1-stimulated WT and M-BKO macrophages identified 419 genes that are more highly expressed in M1-activated M-BKO macrophages (FDR &lt; 0.05, p&lt;0.05, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B</xref> and <xref ref-type="supplementary-material" rid="fig5sdata1">Figure 5—source data 1</xref>). Most-enriched categories included stress and inflammatory responses that contained <italic>Il1b</italic> and other Hif-1α target genes, such as <italic>S100a8</italic>/<italic>S100a9</italic> (<xref ref-type="bibr" rid="bib17">Grebhardt et al., 2012</xref>). Other top enriched pathways were protein catabolism and amino-acid transport. These pathways included genes encoding plasma membrane amino-acid transporters (e.g., <italic>Slc7a2</italic>, <italic>Slc7a8</italic>, <italic>Slc7a11</italic>, <italic>Slc38a2</italic> and <italic>Slc38a7</italic>) as well as ubiquitin-activating, -conjugating and -ligating enzymes that target proteins for proteasomal degradation (e.g., ubiquitin-like modifier-activating enzyme 6 [<italic>Uba6</italic>], ubiquitin conjugating enzymes [<italic>Ube2q2</italic> and <italic>Ube2e3</italic>], ring finger proteins [<italic>Rnf12</italic>, <italic>Rnf56</italic>, <italic>Rnf128</italic>, and <italic>Rnf171]</italic>, cullin 3 [<italic>Cul3</italic>] and <italic>Cul5</italic>, and ubiquitin protein ligase e3a [<italic>Ube3a</italic>]) (<xref ref-type="fig" rid="fig5">Figure 5A–B</xref>). The expression of enzymes that are involved in the breakdown of branched-chain amino acids was also higher in M1-activated M-BKO cells, including branched-chain keto acid dehydrogenase E1 subunit beta (<italic>Bckdhb</italic>) and methylmalonate semialdehyde dehydrogenase (<italic>Mmsdh</italic>). These results are consistent with the increased amino-acid catabolism that was observed in metabolite assays (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Interestingly, certain genes described above, notably <italic>Slc7a8</italic>, appeared to be counter-regulated by Hif-1α, as their induction by M1 stimulation was blunted in M-HKO macrophages (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C</xref>).</p><p>Slc7a8, also called L-type amino-acid transporter 2 (Lat2), transports neutral amino acids that could be converted to succinate and could potentially contribute to Hif-1α protein stabilization. In line with increased amino acid-metabolism, extracellular flux analysis showed that M-BKO macrophages showed enhanced glutamine utilization compared to WT cells, which was blocked by 2-amino-bicyclo-(2,2,1)-heptane-2-carboxylate (BCH), an L-type amino-acid transporter inhibitor (<xref ref-type="bibr" rid="bib7">Christensen et al., 1969</xref>; <xref ref-type="bibr" rid="bib44">Segawa et al., 1999</xref>; <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D</xref>). BCH decreased and normalized levels of Hif-1α protein between WT and M-BKO macrophages (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). In addition, treatment with either BCH or DMM suppressed the expression of <italic>Il1b</italic>, <italic>Slc7a8</italic> and <italic>Slc7a11</italic> induced by M1 stimulation (<xref ref-type="fig" rid="fig5">Figure 5D</xref>). The combination of BCH and DMM did not exert a greater effect over that of DMM alone. Thus, amino-acid metabolism is upregulated in response to dysregulated energy metabolism in M-BKO macrophages, which contributes to increased oxidative stress and Hif-1α activation.</p></sec><sec id="s2-5"><title>Macrophage <italic>Bmal1</italic> gene deletion promotes an immune-suppressive tumor-associated macrophage phenotype and enhances tumor growth</title><p>It has been suggested that myeloid-specific <italic>Bmal1</italic> deletion disrupts diurnal monocyte trafficking, thereby increasing sepsis-induced systemic inflammation and mortality (<xref ref-type="bibr" rid="bib35">Nguyen et al., 2013</xref>). Our results suggest that the cell-autonomous function of Bmal1 on macrophage metabolism and Hif-1α activation may contribute to the reported phenotype. Hif-1α regulates the polarization of M1 and tumor-associated macrophages, both of which are under energetically challenged conditions. We sought to determine whether Bmal1–Hif-1α crosstalk plays a role in modulating TAM activation through a mechanism similar to that in M1 stimulation. Treatment of macrophages with conditioned medium from primary B16-F10 tumors (T-CM) increased the expression of both <italic>Bmal1</italic> mRNA and Bmal1 protein (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). When compared to WT macrophages, M-BKO macrophages showed enhanced mROS production and Hif-1α protein induced by T-CM (<xref ref-type="fig" rid="fig6">Figure 6B–C</xref>). Tracking with Hif-1α stabilization, aerobic glycolysis was upregulated by T-CM pretreatment in WT and to a greater extent in M-BKO macrophages (<xref ref-type="fig" rid="fig6">Figure 6D</xref>). T-CM elicited an energetic stress gene expression signature resembling that of M1 stimulation, which included upregulation of amino acid metabolism (<italic>Arg1</italic>, <italic>Slc7a8</italic> and <italic>Bckdhb</italic>) and oxidative stress (<italic>Slc7a11</italic> and <italic>Nqo1</italic>) pathways in WT macrophages that were further induced by M-BKO (<xref ref-type="fig" rid="fig6">Figure 6E</xref>).</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Bmal1 regulates tumor-associated macrophage polarization.</title><p>(<bold>A</bold>) Bmal1 gene expression (left panel) and protein levels (right panel) in WT macrophages treated with control medium or increasing doses of B16-F10 tumor-conditioned medium (T-CM, diluted 1:3 or 1:1 with control medium) for 8 hr. N = 3 biological replicates for qPCR, statistical analysis was performed using Student’s T test. (<bold>B</bold>) Measurement of mROS using MitoSox Red (mean fluorescent intensity, MFI) in mitochondria from macrophages treated with control medium or T-CM diluted 1:1 with control medium for 1 hr. N = 3 biological replicates, statistical analysis was performed using Student’s T test. (<bold>C</bold>) Hif-1α protein levels in WT and M-BKO macrophages treated with control medium, T-CM diluted 1:1 with control medium, or undiluted T-CM for 4 hr. (<bold>D</bold>) Glycolytic stress test in macrophages pretreated with control medium or T-CM diluted 1:1 with control medium for 4 hr. N = 5 biological replicates. Statistical analysis was performed using two-way ANOVA comparing T-CM-treated M-BKO with WT cells across the time course. (<bold>E</bold>) Relative expression of genes involved in amino-acid metabolism and oxidative stress response in macrophages treated with control medium or T-CM diluted 1:3 with control medium for 8 hr, as determined by qPCR. N = 3 biological replicates, statistical analysis was performed using Student’s T test. (<bold>F</bold>) Tumor volume in male (left) and female (right) WT and M-BKO mice. 300,000 B16-F10 cells were injected subcutaneously into the right flank. N = 18 (male) and 8 (female) mice, statistical analysis was performed using two-way ANOVA for WT vs M-BKO mice across the time course. (<bold>G</bold>) Gene expression for F4/80<sup>+</sup> cells isolated from B16-F10 tumors or spleens of female mice 14 days after injection. Tissues from six mice per genotype were pooled into three groups for leukocyte isolation. Statistical analysis was performed using Student’s T test. Data are presented as mean ± S.E.M. *, p&lt;0.05. Experiments were repeated at least twice.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54090-fig6-v2.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Increased mROS levels and glucose uptake in M-BKO TAMs.</title><p>(<bold>A</bold>) Tumor volumes of B16-F10 subcutaneous allografts in 3-month-old female WT and M-BKO mice 14 days after tumor cell injection. Each mouse was injected with 500,000 B16-F10 cells in the right and left flanks, and tumors from each mouse were pooled for immune cell isolation and flow cytometry. N = 4 mice, with two tumors per mouse. (<bold>B</bold>, <bold>C</bold>) mROS production and glucose uptake by tumor-associated CD45<sup>+</sup>F4/80<sup>+</sup> cells determined by flow cytometry (mean fluorescent intensities) of Mitosox Red and 2-NBDG staining, respectively. N = 4. Statistical analysis was performed using Student’s T test. Data are presented as mean ± S.E.M. *, p&lt;0.05.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54090-fig6-figsupp1-v2.tif"/></fig></fig-group><p>Subsequently, we employed a mouse model of melanoma through subcutaneous injection of B16-F10 melanoma cells to assess the impact of myeloid <italic>Bmal1</italic> deletion on tumor growth. Tumor volume was increased in both male and female M-BKO mice compared to WT controls (<xref ref-type="fig" rid="fig6">Figure 6F</xref>). Furthermore, the expression of <italic>Arg1</italic>, <italic>Slc7a8</italic> and <italic>Slc7a11</italic> was upregulated in F4/80<sup>+</sup> cells isolated from tumors but not spleens of M-BKO mice compared to WT animals (<xref ref-type="fig" rid="fig6">Figure 6G</xref>). Of note, the mRNA levels of <italic>Arg1</italic>, <italic>Slc7a8</italic> and <italic>Slc7a11</italic> were substantially higher in tumor than in splenic F4/80<sup>+</sup> cells. Flow cytometry analyses of F4/80<sup>+</sup> cells from primary tumors stained with Mitosox Red and 2-deoxy-2-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-D-glucose (2-NBDG) were employed to assess mROS production and glucose uptake, respectively. M-BKO TAMs exhibited a trend towards increased mROS and significantly higher glucose uptake, compared to WT TAMs (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A-C</xref>). These results demonstrate that the metabolic reprogramming observed in T-CM-primed BMDM is shared by TAMs.</p><p>To confirm that macrophage Bmal1 modulates tumor growth cell-autonomously and to assess the effect of TAMs on anti-tumor immune response within the same host environment, we co-injected B16-F10 cells with either WT or M-BKO macrophages into the right or left flanks, respectively, of WT mice. Tumor growth rate was substantially higher when the tumor cells were co-injected with M-BKO macrophages than when co-injected with WT cells (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). In concert, co-injection with M-BKO macrophages led to a reduction in the CD8<sup>+</sup> T cell population among tumor-infiltrating CD45<sup>+</sup> leukocytes, as well as to functionally primed CD8<sup>+</sup> T and NK cells that expressed Ifn-γ protein following stimulation with phorbol myristate acetate and ionomycin ex vivo (<xref ref-type="fig" rid="fig7">Figure 7B</xref>). Similar results were obtained when the co-injections were performed in M-BKO mice (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1A, B</xref>).</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Macrophage Bmal1 modulates the antitumor activity.</title><p>(<bold>A</bold>) Tumor volume in WT male mice co-injected with 500,000 B16-F10 cells and either 500,000 WT or M-BKO macrophages as indicated. N = 22 mice, statistical analysis was performed using two-way ANOVA to compare WT vs M-BKO macrophage co-injection across the time course. (<bold>B</bold>) Flow cytometric analysis of tumor-infiltrating CD8<sup>+</sup> T cells (CD45<sup>+</sup>CD3<sup>+</sup>CD8a<sup>+</sup> cells, left panel) and NK cells (CD45<sup>+</sup>CD3<sup>–</sup>NK1.1<sup>+</sup> cells, right panel) stimulated ex vivo with phorbol 12-myristate 13-acetate and ionomycin for Ifn-γ co-staining. Tumors represented in panel (<bold>A</bold>) were pooled into three groups prior to isolation of infiltrating leukocytes for flow cytometry. Statistical analysis was performed using Student’s T test. (<bold>C</bold>) Tumor volume in WT male mice co-injected with 500,000 B16-F10 cells and either 500,000 WT or M-BKO macrophages, supplemented without or with dimethylmalonate (DMM, approximately 150 mg/kg body weight per day in mouse diet). N = 8 mice, statistical analysis was performed using two-way ANOVA to compare WT vs M-BKO macrophage co-injection on control diet, or to compare WT macrophage co-injection on the control diet vs WT or M-BKO macrophage co-injection on the DMM-supplemented diet across the time course. Data are presented as mean ± S.E.M. *, p&lt;0.05. Experiments were repeated at least twice.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54090-fig7-v2.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>Macrophage Bmal1 regulates tumor growth in a cell-autonomous manner.</title><p>(<bold>A</bold>) Tumor volume in M-BKO male mice co-injected with 500,000 B16-F10 cells and either 500,000 WT or M-BKO macrophages as indicated. N = 6 mice, statistical analysis was performed using two-way ANOVA to compare WT vs M-BKO macrophage co-injection across the time course. (<bold>B</bold>) Flow cytometric analyses of tumor-infiltrating CD8<sup>+</sup> T cells (CD45<sup>+</sup>CD3<sup>+</sup>CD8a<sup>+</sup> cells, left panel) and NK cells (CD45<sup>+</sup>CD3<sup>–</sup>NK1.1<sup>+</sup> cells, right panel) stimulated ex vivo with phorbol 12-myristate 13-acetate and ionomycin for Ifn-γ co-staining. Tumors that are represented in panel (<bold>A</bold>) were pooled into three groups prior to isolation of infiltrating leukocytes for flow cytometric analyses. Statistical analysis was performed using Student’s T test. Data are presented as mean ± S.E.M. *, p&lt;0.05. (<bold>C</bold>) Hif-1α protein levels in WT macrophages treated with (from left to right) control medium or B16-F10 tumor-conditioned medium (T–CM) diluted 1:1 with control medium without or with co-treatment with 10 mM dimethyl malonate (DMM) for 4 hr. (<bold>D</bold>) <italic>Arg1</italic> gene expression in WT macrophages treated as in panel (<bold>C</bold>) for 8 hr. N = 3 biological replicates. Statistical analysis was performed using Student’s T test. Experiments were repeated at least twice. (<bold>E</bold>) Schematic showing the working model for Bmal1–Hif-1α crosstalk in the regulation of macrophage bioenergetics and effector functions. Both M1 and tumor-associated macrophages share similar energetically stressed states. Bmal1 preserves mitochondrial oxidative metabolism while reducing oxidative stress to modulate Hif-1α activity and support proper effector functions. Deletion of <italic>Bmal1</italic> in the macrophage leads to reliance on glycolytic metabolism and alternative fuel utilization, notably amino-acid metabolism, which further promotes mROS production and Hif-1α protein stabilization. Increased amino-acid utilization by M-BKO macrophages may lead to depletion of amino acids that are critical for lymphocyte activation and cytotoxic function, thereby suppressing anti-tumor immunity in the tumor microenvironment.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54090-fig7-figsupp1-v2.tif"/></fig></fig-group><p>We next sought to address the importance of oxidative stress in TAM activation. Similar to M1 macrophages, DMM blocked Hif-1α protein accumulation and attenuated <italic>Arg1</italic> upregulation in T-CM-treated macrophages (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1C-D</xref>). Administering DMM (~150 mg/kg body/day) at the time of macrophage-tumor cell co-inoculation effectively suppressed melanoma tumor growth and normalized the difference in tumor promoting effects between WT and M-BKO macrophages (<xref ref-type="fig" rid="fig7">Figure 7C</xref>). These results reveal a unifying mechanism by which Bmal1 controls macrophage effector functions through bioenergetic regulation, and suggest that targeting oxidative stress may provide a means to modulate the anti-tumor activity of TAMs.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>It has been reported that sepsis exerts a long-lasting effect on circadian rhythm alteration in mice (<xref ref-type="bibr" rid="bib31">Marpegán et al., 2005</xref>; <xref ref-type="bibr" rid="bib36">O'Callaghan et al., 2012</xref>). In the current study, we show that inflammatory stimulants, including Ifn-γ/LPS and tumor-derived factors, control the expression of the circadian master regulator Bmal1 in the macrophages. Our data further demonstrate that Bmal1 is an integral part of the metabolic regulatory network and modulates macrophage activation, in part through crosstalk with Hif-1α. The Bmal1–Hif-1α regulatory loop regulates the balance between oxidative and glycolytic metabolism in energetically stressed macrophages that have distinct effector functions. <italic>Bmal1</italic> loss-of-function in M1-activated macrophages causes mitochondrial dysfunction, thereby potentiating mROS production and Hif-1α protein stabilization, which probably contributes to the increased sepsis-induced inflammatory damage reported for M-BKO mice (<xref ref-type="bibr" rid="bib35">Nguyen et al., 2013</xref>). Within the tumor microenvironment, macrophage <italic>Bmal1</italic> gene deletion leads to compromised anti-tumor immunity and accelerated tumor growth in a mouse melanoma model. Therefore, the Bmal1–Hif-1α nexus serves as a metabolic switch that may be targeted to control macrophage effector functions.</p><p>Much attention has been focused on how inflammatory stimuli disrupt mitochondrial metabolism as a means to generate signaling molecules, including TCA metabolites and mROS. The analysis of transcriptional modules that are involved in macrophage inflammatory response reveals a coordinated effort in the control of mitochondrial activity. The expression of several regulators of mitochondrial biogenesis (e.g., <italic>Pparg</italic>) is downregulated rapidly after M1 stimulation and rebounds after between 8–12 hr, when <italic>Bmal1</italic> and <italic>Ppard</italic> expression is induced (<xref ref-type="fig" rid="fig1">Figure 1</xref>). Several lines of evidence indicate that Bmal1 plays a key role in restoring mitochondrial function and in modulating a Hif-1α-mediated inflammatory response. The expression of transcription factors that are known to control mitochondrial bioenergetics (i.e., Pparγ and Pparδ) is downregulated by M-BKO. Macrophages that are deficient in <italic>Bmal1</italic> are unable to sustain mitochondrial function upon M1 stimulation and fail to recover from suppressed mitochondrial respiration 24 hr following acute LPS treatment. By contrast, Bmal1 gain-of-function in RAW 246.7 macrophages promotes oxidative metabolism. It is interesting to note that the dysregulated mitochondrial respiration phenotype of M-BKO macrophages occurs as early as 2 hr after M1 activation, whereas Bmal1 protein accumulation peaks at 12 hr. This early phase of regulation could be mediated by downstream pathways of the circadian regulatory network. RNA-seq analyses reveal that components of the molecular clock are induced by M1 (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). Notably, Nr1d1/Nr1d2 have been shown to regulate macrophage inflammatory gene expression negatively (<xref ref-type="bibr" rid="bib24">Lam et al., 2013</xref>) and promote mitochondrial function in skeletal muscle (<xref ref-type="bibr" rid="bib55">Woldt et al., 2013</xref>). The induction of <italic>Nr1d2</italic> by M1 was almost completely abolished in M-BKO macrophages (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). In concert, the expression of <italic>Cx3cr1</italic>, a direct target suppressed by Nr1d1/Nr1d2 (<xref ref-type="bibr" rid="bib24">Lam et al., 2013</xref>), is higher in M1-activated M-BKO macrophages than in WT cells (<xref ref-type="supplementary-material" rid="fig5sdata1">Figure 5—source data 1</xref>). This suppressive effect of Nr1d1/Nr1d2 may dampen the inflammatory damage to mitochondrial function at the initial stage of M1 activation. Another potential mechanism is through enhanced Hif-1α activity by M-BKO, which is evident after 4 hr of M1 activation (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Hif-1α suppresses mitochondrial respiration through multiple mechanisms (<xref ref-type="bibr" rid="bib51">Thomas and Ashcroft, 2019</xref>). For instance, it regulates the glycolytic program favoring lactate production and controls the expression of Bnip3 to promote mitophagy. M-BKO macrophages exhibit a higher lactate production rate 4 hr after M1 stimulation (<xref ref-type="fig" rid="fig3">Figure 3D</xref>) and this phenotype was observed as early as 2 hr after M1 stimulation (data not shown). Bnip3 protein accumulation is also increased, although appreciable amounts of Bnip3 protein could only be detected at 8 hr after M1 treatment (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>). Bmal1 is best known for its role in circadian regulation and has been shown to control rhythmic monocyte recruitment, which plays a key role in the immune response against pathogens and in limiting infection-associated inflammatory damage (<xref ref-type="bibr" rid="bib35">Nguyen et al., 2013</xref>). Our data suggest that LPS or M1 stimulation could ‘reset the clock’ by inducing/resynchronizing the expression of <italic>Bmal1</italic>. In this context, Bmal1 may regulate energy metabolism to support diurnal monocyte trafficking, and may control the timing of glycolytic to oxidative metabolism transition during M1 activation that dictates the extent of Hif-1α activation and the associated inflammatory response.</p><p>Both Bmal1 and Hif-1α belong to the basic helix-loop-helix (bHLH) transcription factor family and have similar domain structures. However, they appear to regulate opposing metabolic programs, with Hif-1α serving as a master regulator of aerobic glycolysis and Bmal1 as a positive regulator of oxidative metabolism (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1E</xref>). The crosstalk between these two bHLH transcription factors is in part mediated by succinate and SDH/complex II-facilitated mROS production. Succinate is one of the entry points for anerplerosis that attempts to replenish the TCA cycle metabolites that are depleted by disruption of mitochondrial oxidative metabolism. Increased protein or amino-acid catabolism provides a source of anerplerotic reactions. Succinate accumulation and the subsequent oxidation to fumarate, however, generate mROS, which stabilize Hif-1α protein and thus drive aerobic glycolysis. Our data suggest that amino-acid metabolism appears to be down- and upregulated by Bmal1 and Hif-1α, respectively, as demonstrated by the regulation of <italic>Arg1</italic> and <italic>Slc7a8</italic> gene expression. As described above, Hif-1α has also been shown to regulate Bnip3-mediated mitophagy that reduces mitochondrial oxidative capacity (<xref ref-type="bibr" rid="bib58">Zhang et al., 2008</xref>). Therefore, Bmal1-controlled mitochondrial metabolism provides a break to this feedforward cycle that limits inflammatory damage. In line with this, previous work has demonstrated that myeloid <italic>Bmal1</italic> knockout mice have reduced survival rate upon <italic>L. monocytogenes</italic> infection (<xref ref-type="bibr" rid="bib35">Nguyen et al., 2013</xref>). These observations indicate a tightly regulated metabolic program in the macrophage that executes effector functions and places Bmal1-regulated mitochondrial metabolism at the center of an orderly and balanced immune response.</p><p>Despite being characterized as M2-like, TAMs share several common features with M1-activated macrophages: both function under nutrient-restricted conditions and Hif-1α is required for their activation. Previous studies implicate a glycolytic preference for TAMs in breast, thyroid, and pancreatic cancer (<xref ref-type="bibr" rid="bib2">Arts et al., 2016</xref>; <xref ref-type="bibr" rid="bib30">Liu et al., 2017</xref>; <xref ref-type="bibr" rid="bib41">Penny et al., 2016</xref>). Our data confirm that T-CM treatment enhances glycolysis in the macrophage accompanied by increased Hif-1α protein (<xref ref-type="fig" rid="fig6">Figure 6C, D</xref>). <italic>Arg1</italic>, originally defined as an M2 marker, is a <italic>bona fide</italic> target of Hif-1α that is upregulated in TAMs and M1 macrophages. Arg1 is involved in the urea cycle that detoxifies ammonia, and its induction supports the upregulation of amino-acid catabolism. M-BKO macrophages show increased mROS, glycolytic metabolism, Hif-1α stabilization and upregulation of <italic>Arg1</italic> and <italic>Slc7a8</italic> upon treatment with T-CM. Dysregulated amino-acid metabolism has been shown to impact immune cell activation. Arginine depletion impairs lymphocyte function, as arginine is required for effector T cell and NK cell proliferation and maintenance (<xref ref-type="bibr" rid="bib16">Geiger et al., 2016</xref>; <xref ref-type="bibr" rid="bib25">Lamas et al., 2012</xref>; <xref ref-type="bibr" rid="bib48">Steggerda et al., 2017</xref>). Slc7a8 transports neutral amino acids, including branched-chain amino acids that are essential for lymphocyte activation and cytotoxic function (<xref ref-type="bibr" rid="bib46">Sinclair et al., 2013</xref>; <xref ref-type="bibr" rid="bib52">Tsukishiro et al., 2000</xref>). Therefore, the increased amino-acid utilization by M-BKO macrophages may contribute to the observed reduction in populations of Ifn-γ-producing CD8<sup>+</sup> T and NK cells in tumor-infiltrating CD45<sup>+</sup> leukocytes (<xref ref-type="fig" rid="fig7">Figure 7B</xref> and <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1B</xref>). The fact that amino-acid or protein metabolism and oxidative stress genes (<italic>Arg1</italic>, <italic>Slc7a8</italic> and <italic>Slc7a11</italic>) are upregulated in TAMs, compared to splenic macrophages (<xref ref-type="fig" rid="fig6">Figure 6G</xref>), supports the notion that energetic stress is also a key determinant of TAM polarization. As a proof-of-principle approach, we show that DMM treatment blocks T-CM induced Hif-1α protein stabilization in vitro and suppresses tumor growth in vivo. Thus, M1 macrophages opt for an inefficient way to produce ATP, whereas TAMs are limited in energy allocations. Both of these processes result in an energetically challenged state in which Bmal1–Hif-1α crosstalk controls the metabolic adaptation that shapes macrophage polarization. Future studies investigating mechanisms that harness this energetic stress may identify means to modulate immune cell functions effectively.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th valign="top">Reagent type <break/>(species) or resource</th><th valign="top">Designation</th><th valign="top">Source or reference</th><th valign="top">Identifiers</th><th valign="top">Additional <break/>information</th></tr></thead><tbody><tr><td valign="top">Strain, strain background (<italic>Mus musculus</italic>)</td><td valign="top">B6.129S4(CG)-<italic>Arntl<sup>tm1Weit</sup></italic>/J</td><td valign="top">The Jackson Laboratory</td><td valign="top">JAX: 007668</td><td valign="top">Carry loxp sites flanking exon 8 of the <italic>Bmal1</italic> gene</td></tr><tr><td valign="top">Strain, strain background (<italic>Mus musculus</italic>)</td><td valign="top">B6.129-<italic>Hif1a<sup>tm3Rsjo</sup></italic>/J</td><td valign="top">The Jackson Laboratory</td><td valign="top">JAX: 007561</td><td valign="top">Carry loxp sites flanking exon 2 of the <italic>Hif1a</italic> gene</td></tr><tr><td valign="top">Strain, strain background (<italic>Mus musculus</italic>)</td><td valign="top">B6.129P2-<italic>Lyz2<sup>tm1(cre)lfo</sup></italic>/J</td><td valign="top">The Jackson Laboratory</td><td valign="top">JAX: 004781</td><td valign="top">Myeloid-specific Cre recombinase expression</td></tr><tr><td valign="top">Antibody</td><td valign="top">Mouse monoclonal anti-Bmal1 (clone B-1)</td><td valign="top">Santa Cruz Biotechnology</td><td valign="top">Cat# sc365645; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10841724">AB_10841724</ext-link></td><td valign="top">WB (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rabbit polyclonal anti-Hif-1α</td><td valign="top">Novus Biologicals</td><td valign="top">Cat# NB100-449; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10001045">AB_10001045</ext-link></td><td valign="top">WB (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rabbit monoclonal anti-Bnip3 <break/>(clone EPR4034)</td><td valign="top">Abcam</td><td valign="top">Cat# ab109362; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10864714">AB_10864714</ext-link></td><td valign="top">WB (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rabbit polyclonal anti-β-tubulin</td><td valign="top">Cell Signaling Technology</td><td valign="top">Cat# 2146; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2210545">AB_2210545</ext-link></td><td valign="top">WB (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rabbit monoclonal anti-β-Actin (clone 13E5)</td><td valign="top">Cell Signaling Technology</td><td valign="top">Cat# 4970; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2223172">AB_2223172</ext-link></td><td valign="top">WB (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rat monoclonal anti-CD45 (clone 30-F11), PerCP/Cy5.5-conjugated</td><td valign="top">Biolegend</td><td valign="top">Cat# 103132; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_893340">AB_893340</ext-link></td><td valign="top">Flow cytometry (1 μL per test)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Armenian hamster monoclonal anti-CD3ε (clone 145–2 C11), PE/Cy7-conjugated</td><td valign="top">Biolegend</td><td valign="top">Cat# 100320; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_312685">AB_312685</ext-link></td><td valign="top">Flow cytometry (2.5 μL per test)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rat monoclonal anti-CD8a (clone 53–6.7), Alexa Fluor 700-conjugated</td><td valign="top">Biolegend</td><td valign="top">Cat# 100730; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_493703">AB_493703</ext-link></td><td valign="top">Flow cytometry (0.5 μL per test)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Mouse monoclonal anti-NK1.1 (clone PK136), APC-conjugated</td><td valign="top">Biolegend</td><td valign="top">Cat# 108710</td><td valign="top">Flow cytometry (5 μL per test)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rat monoclonal anti-F4/80 (clone BM8), Alexa Fluor 488-conjugated</td><td valign="top">Biolegend</td><td valign="top">Cat# 123120; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_893479">AB_893479</ext-link></td><td valign="top">Flow cytometry (5 μL per test)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rat monoclonal anti-F4/80 (clone BM8), APC-conjugated</td><td valign="top">Biolegend</td><td valign="top">Cat# 123115; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_%20893493">AB_893493</ext-link></td><td valign="top">Flow cytometry (2.5 μL per test)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rat monoclonal anti-Ifn-γ (clone XMG1.2), PE-conjugated</td><td valign="top">ThermoFisher Scientific</td><td valign="top">Cat# 12-7311-81, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_466192">AB_466192</ext-link></td><td valign="top">Flow cytometry (1 μL per test)</td></tr><tr><td valign="top">Peptide, recombinant protein</td><td valign="top">Recombinant murine interferon-γ</td><td valign="top">Peprotech</td><td valign="top">Cat# 315–05</td><td valign="top">Used 10 ng/mL final concentration</td></tr><tr><td valign="top">Peptide, recombinant protein</td><td valign="top">Recombinant murine interleukin-4</td><td valign="top">Peprotech</td><td valign="top">Cat# 214–14</td><td valign="top">Used 10 ng/mL final concentration</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">36b4_F</td><td valign="top">This paper</td><td valign="top">qPCR primer</td><td valign="top"><named-content content-type="sequence">AGATGCAGCAGATCCGCAT</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">36b4_R</td><td valign="top">This paper</td><td valign="top">qPCR primer</td><td valign="top"><named-content content-type="sequence">GTTCTTGCCCATCAGCACC</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Arg1_F</td><td valign="top">This paper</td><td valign="top">qPCR primer</td><td valign="top"><named-content content-type="sequence">CGTAGACCCTGGGGAACACTAT</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Arg1_R</td><td valign="top">This paper</td><td valign="top">qPCR primer</td><td valign="top"><named-content content-type="sequence">TCCATCACCTTGCCAATCCC</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Bckdhb_F</td><td valign="top">This paper</td><td valign="top">qPCR primer</td><td valign="top"><named-content content-type="sequence">TGGGGCTCTCTACCATTCTCA</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Bckdhb_R</td><td valign="top">This paper</td><td valign="top">qPCR primer</td><td valign="top"><named-content content-type="sequence">GGGGTATTACCACCTTGATCCC</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Bmal1_F</td><td valign="top">This paper</td><td valign="top">qPCR primer</td><td valign="top"><named-content content-type="sequence">AGGATCAAGAATGCAAGGGAGG</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Bmal1_R</td><td valign="top">This paper</td><td valign="top">qPCR primer</td><td valign="top"><named-content content-type="sequence">TGAAACTGTTCATTTTGTCCCGA</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">cMyc_F</td><td valign="top">This paper</td><td valign="top">qPCR primer</td><td valign="top"><named-content content-type="sequence">CAGCGACTCTGAAGAAGAGCA</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">cMyc_R</td><td valign="top">This paper</td><td valign="top">qPCR primer</td><td valign="top"><named-content content-type="sequence">GACCTCTTGGCAGGGGTTTG</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Cry1_F</td><td valign="top">This paper</td><td valign="top">qPCR primer</td><td valign="top"><named-content content-type="sequence">CACTGGTTCCGAAAGGGACTC</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Cry1_R</td><td valign="top">This paper</td><td valign="top">qPCR primer</td><td valign="top"><named-content content-type="sequence">CTGAAGCAAAAATCGCCACCT</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Gclc_F</td><td valign="top">This paper</td><td valign="top">qPCR primer</td><td valign="top"><named-content content-type="sequence">CATCCTCCAGTTCCTGCACA</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Gclc_R</td><td valign="top">This paper</td><td valign="top">qPCR primer</td><td valign="top"><named-content content-type="sequence">ATGTACTCCACCTCGTCACC</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Hif1a_F</td><td valign="top">This paper</td><td valign="top">qPCR primer</td><td valign="top"><named-content content-type="sequence">GAACGAGAAGAAAAATAGGATGAGT</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Hif1a_R</td><td valign="top">This paper</td><td valign="top">qPCR primer</td><td valign="top"><named-content content-type="sequence">ACTCTTTGCTTCGCCGAGAT</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Hmox1_F</td><td valign="top">This paper</td><td valign="top">qPCR primer</td><td valign="top"><named-content content-type="sequence">CAGAGCCGTCTCGAGCATAG</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Hmox1_R</td><td valign="top">This paper</td><td valign="top">qPCR primer</td><td valign="top"><named-content content-type="sequence">CAAATCCTGGGGCATGCTGT</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Il1b_F</td><td valign="top">This paper</td><td valign="top">qPCR primer</td><td valign="top"><named-content content-type="sequence">AGCTTCAGGCAGGCAGTATC</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Il1b_R</td><td valign="top">This paper</td><td valign="top">qPCR primer</td><td valign="top"><named-content content-type="sequence">AAGGTCCACGGGAAAGACAC</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Ldha_F</td><td valign="top">This paper</td><td valign="top">qPCR primer</td><td valign="top"><named-content content-type="sequence">GCGTCTCCCTGAAGTCTCTT</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Ldha_R</td><td valign="top">This paper</td><td valign="top">qPCR primer</td><td valign="top"><named-content content-type="sequence">GCCCAGGATGTGTAACCTTT</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Mgl2_F</td><td valign="top">This paper</td><td valign="top">qPCR primer</td><td valign="top"><named-content content-type="sequence">ccttgcgtttgtcaaaacatgac</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Mgl2_R</td><td valign="top">This paper</td><td valign="top">qPCR primer</td><td valign="top"><named-content content-type="sequence">ctgaggcttatggaactgaggc</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Mmsdh_F</td><td valign="top">This paper</td><td valign="top">qPCR primer</td><td valign="top"><named-content content-type="sequence">GAGGCCTTCAGGTGGTTGAG</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Mmsdh_R</td><td valign="top">This paper</td><td valign="top">qPCR primer</td><td valign="top"><named-content content-type="sequence">GATAGATGGCATGGTCTCTCCC</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Nfe2l2_F</td><td valign="top">This paper</td><td valign="top">qPCR primer</td><td valign="top"><named-content content-type="sequence">GGTTGCCCACATTCCCAAAC</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Nfe2l2_R</td><td valign="top">This paper</td><td valign="top">qPCR primer</td><td valign="top"><named-content content-type="sequence">GCAAGCGACTCATGGTCATC</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Nfkb1_F</td><td valign="top">This paper</td><td valign="top">qPCR primer</td><td valign="top"><named-content content-type="sequence">CCTGCTTCTGGAGGGTGATG</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Nfkb1_R</td><td valign="top">This paper</td><td valign="top">qPCR primer</td><td valign="top"><named-content content-type="sequence">GCCGCTATATGCAGAGGTGT</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Nqo1_F</td><td valign="top">This paper</td><td valign="top">qPCR primer</td><td valign="top"><named-content content-type="sequence">TCTCTGGCCGATTCAGAGTG</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Nqo1_R</td><td valign="top">This paper</td><td valign="top">qPCR primer</td><td valign="top"><named-content content-type="sequence">TGCTGTAAACCAGTTGAGGTTC</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Nr1d2_F</td><td valign="top">This paper</td><td valign="top">qPCR primer</td><td valign="top"><named-content content-type="sequence">TCATGAGGATGAACAGGAACCG</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Nr1d2_R</td><td valign="top">This paper</td><td valign="top">qPCR primer</td><td valign="top"><named-content content-type="sequence">CGGCCAAATCGAACAGCATC</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Ppard_F</td><td valign="top">This paper</td><td valign="top">qPCR primer</td><td valign="top"><named-content content-type="sequence">CAGCCTCAACATGGAATGTC</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Ppard_R</td><td valign="top">This paper</td><td valign="top">qPCR primer</td><td valign="top"><named-content content-type="sequence">TCCGATCGCACTTCTCATAC</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Pparg_F</td><td valign="top">This paper</td><td valign="top">qPCR primer</td><td valign="top"><named-content content-type="sequence">CAGGAGCCTGTGAGACCAAC</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Pparg_R</td><td valign="top">This paper</td><td valign="top">qPCR primer</td><td valign="top"><named-content content-type="sequence">ACCGCTTCTTTCAAATCTTGTCTG</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Slc7a2_F</td><td valign="top">This paper</td><td valign="top">qPCR primer</td><td valign="top"><named-content content-type="sequence">CCCGGGATGGCTTACTGTTT</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Slc7a2_R</td><td valign="top">This paper</td><td valign="top">qPCR primer</td><td valign="top"><named-content content-type="sequence">AGGCCATCACAGCAGAAATGA</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Slc7a8_F</td><td valign="top">This paper</td><td valign="top">qPCR primer</td><td valign="top"><named-content content-type="sequence">GAACCACCCGGGTTCTGAC</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Slc7a8_R</td><td valign="top">This paper</td><td valign="top">qPCR primer</td><td valign="top"><named-content content-type="sequence">TGATGTTCCCTACAATGATACCACA</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Slc7a11_F</td><td valign="top">This paper</td><td valign="top">qPCR primer</td><td valign="top"><named-content content-type="sequence">ATCTCCCCCAAGGGCATACT</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Slc7a11_R</td><td valign="top">This paper</td><td valign="top">qPCR primer</td><td valign="top"><named-content content-type="sequence">GCATAGGACAGGGCTCCAAA</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Stat3_F</td><td valign="top">This paper</td><td valign="top">qPCR primer</td><td valign="top"><named-content content-type="sequence">TGGCAGTTCTCGTCCAC</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Stat3_R</td><td valign="top">This paper</td><td valign="top">qPCR primer</td><td valign="top"><named-content content-type="sequence">CCAGCCATGTTTTCTTTGC</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Bmal1_F</td><td valign="top">This paper</td><td valign="top">Cloning primers</td><td valign="top"><named-content content-type="sequence">GGCGAATTCGCGGACCAGAGAATGGAC</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Bmal1_R</td><td valign="top">This paper</td><td valign="top">Cloning primers</td><td valign="top"><named-content content-type="sequence">GGGCTCGAGCTACAGCGGCCATGGCAA</named-content></td></tr><tr><td valign="top">Cell line (<italic>Mus musculus</italic>)</td><td valign="top">RAW264.7 macrophages</td><td valign="top">ATCC</td><td valign="top">qPCR primer</td><td valign="top">TIB-71</td></tr><tr><td valign="top">Cell line (<italic>Mus musculus</italic>)</td><td valign="top">B16-F10 melanoma cells</td><td valign="top">ATCC</td><td valign="top">qPCR primer</td><td valign="top">CRL-6475</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">pBABE-puro retroviral expression vector (plasmid)</td><td valign="top">Addgene</td><td valign="top">Plasmid #1764</td><td valign="top"/></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">pBABE-Bmal1 (plasmid)</td><td valign="top">This study</td><td valign="top"/><td valign="top">For stable overexpression of mouse <italic>Bmal1</italic></td></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Lipopolysaccharides from <italic>Escherichia coli</italic> K-235</td><td valign="top">Sigma-Aldrich</td><td valign="top">Cat# L2143</td><td valign="top">Final concentration used varied as indicated</td></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Dimethyl malonate</td><td valign="top">Sigma-Aldrich</td><td valign="top">Cat# 136441; <break/>CAS: 108-59-8</td><td valign="top">Used 10 mM final concentration</td></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Sodium succinate dibasic</td><td valign="top">Sigma-Aldrich</td><td valign="top">Cat# 14160; <break/>CAS: 150-90-3</td><td valign="top">Used 10 mM final concentration</td></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">N-acetyl-L-cysteine</td><td valign="top">Sigma-Aldrich</td><td valign="top">Cat# A9165; <break/>CAS: 616-91-1</td><td valign="top">Final concentration used varied as indicated.</td></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">2-deoxy-D-glucose</td><td valign="top">Sigma-Aldrich</td><td valign="top">Cat# D8375; <break/>CAS: 154-17-6</td><td valign="top">Used 50 mM final concentration</td></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Quant-iT ribogreen RNA reagent</td><td valign="top">ThermoFisher Scientific</td><td valign="top">Cat# R11491</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Mitotracker green FM</td><td valign="top">ThermoFisher Scientific</td><td valign="top">Cat# M7514 <break/>CAS: 201860-17-5</td><td valign="top">Used 100 nM final concentration</td></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Mitosox red superoxide indicator</td><td valign="top">ThermoFisher Scientific</td><td valign="top">Cat# M36008</td><td valign="top">Used 5 μM final concentration</td></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">2-NBDG</td><td valign="top">ThermoFisher Scientific</td><td valign="top">Cat# N13195</td><td valign="top">Used 10 μM final concentration</td></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Fixable viability dye eFluor 455uv</td><td valign="top">ThermoFisher Scientific</td><td valign="top">Cat# 65-868-14</td><td valign="top">Flow cytometry (0.5 μL per test)</td></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Fixable viability dye eFluor 506</td><td valign="top">ThermoFisher Scientific</td><td valign="top">Cat# 65-0866-14</td><td valign="top">Flow cytometry (0.5 μL per test)</td></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Oligomycin</td><td valign="top">Abcam</td><td valign="top">Cat# ab141829; CAS: 1404-19-9</td><td valign="top">Used 2 μM final concentration</td></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Rotenone</td><td valign="top">Abcam</td><td valign="top">Cat# ab143145 <break/>CAS: 83-79-4</td><td valign="top">Used 1 μM final concentration</td></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Antimycin A</td><td valign="top">Sigma-Aldrich</td><td valign="top">Cat# A8674; <break/>CAS: 1397-94-0</td><td valign="top">Used 1 μM final concentration</td></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone (FCCP)</td><td valign="top">Santa Cruz Biotechnology</td><td valign="top">Cat# sc203578 <break/>CAS: 370-86-5</td><td valign="top">Used 0.5 μM final concentration</td></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Phorbol 12-myristate 13-acetate (PMA)</td><td valign="top">Sigma-Aldrich</td><td valign="top">Cat# P8139; <break/>CAS: 16561-29-8</td><td valign="top">Used 20 ng/mL final concentration</td></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Ionomycin calcium salt from <italic>Streptomyces conglobatus</italic></td><td valign="top">Sigma-Aldrich</td><td valign="top">Cat# I0634; <break/>CAS: 56092-82-1</td><td valign="top">Used 1 μg/mL final concentration</td></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Brefeldin A</td><td valign="top">Cell Signaling Technology</td><td valign="top">Cat# 9972S; <break/>CAS: 20350-15-6</td><td valign="top">Used 10 μg/mL final concentration</td></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">BCA protein assay kit</td><td valign="top">ThermoFisher Scientific</td><td valign="top">Cat# 23227</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Seahorse XF24 FluxPak</td><td valign="top">Agilent</td><td valign="top">Cat# 102070–00</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Foxp3/Transcription factor staining buffer set</td><td valign="top">ThermoFisher Scientific</td><td valign="top">Cat# 00-5523-00</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">TruSeq stranded mRNA library prep kit</td><td valign="top">Illumina</td><td valign="top">Cat# RS-122–2101</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Dynabeads sheep anti-rat IgG</td><td valign="top">ThermoFisher Scientific</td><td valign="top">Cat # 11035</td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">STRING</td><td valign="top"><xref ref-type="bibr" rid="bib53">von Mering, 2004</xref></td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://string-db.org/">https://string-db.org/</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">DAVID</td><td valign="top"><xref ref-type="bibr" rid="bib20">Huang et al., 2009</xref></td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://david-d.ncifcrf.gov/">https://david-d.ncifcrf.gov/</ext-link></td><td valign="top"/></tr><tr><td valign="top">Other</td><td valign="top">Thioglycollate medium</td><td valign="top">Sigma-Aldrich</td><td valign="top">Cat# T9032</td><td valign="top"/></tr><tr><td valign="top">Other</td><td valign="top">Bovine serum albumin, fatty acid free</td><td valign="top">Gemini Bio-Products</td><td valign="top">Cat# 700–107P</td><td valign="top"/></tr><tr><td valign="top">Other</td><td valign="top">Collagen I protein, rat tail</td><td valign="top">ThermoFisher Scientific</td><td valign="top">Cat# A1048301</td><td valign="top"/></tr><tr><td valign="top">Other</td><td valign="top">Collagenase type IV</td><td valign="top">ThermoFisher Scientific</td><td valign="top">Cat# 17104019</td><td valign="top"/></tr><tr><td valign="top">Other</td><td valign="top">Recombinant DNase I, RNase-free</td><td valign="top">Affymetrix</td><td valign="top">Cat# 78411</td><td valign="top"/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Reagents</title><p>Lipopolysaccharide (LPS) from <italic>Escherichia coli</italic> strain K-235 (L2143) was from Sigma-Aldrich. Recombinant murine Ifn-γ (315-05) and Il-4 (214–14) were from Peprotech. The ETC complex II inhibitor dimethyl malonate (136441) and the L-type amino acid transport inhibitor 2-amino-2-norbornanecarboxylic acid, or BCH, (A7902) were from Sigma-Aldrich.</p></sec><sec id="s4-2"><title>Animals</title><p>All animal studies were approved by the Harvard Medical Area Standing Committee on Animal Research. Animals were housed in a pathogen-free barrier facility at the Harvard T.H. Chan School of Public Health. <italic>Bmal1<sup>fl/fl</sup></italic> (stock # 007668), <italic>Hif1a <sup>fl/fl</sup></italic> (stock # 007561), and <italic>Lyz2-Cre</italic> (stock # 004781) mice in the C57BL/6J background were obtained from Jackson laboratories and were originally contributed by Drs Charles Weitz, Dmitriy Lukashev, and Irmgard Foerster, respectively. Floxed mice were crossed with <italic>Lyz2-Cre</italic> mice to generate myeloid-specific <italic>Bmal1</italic> and <italic>Hif1a</italic> knockout mice. Myeloid-specific <italic>Bmal1</italic> knockout mice were crossed with <italic>Hif1a<sup>fl/fl</sup></italic> mice, and the resulting heterozygotes were crossed to generate myeloid-specific <italic>Bmal1</italic> and <italic>Hif1a</italic> double-knockout mice. The genotypes were validated by both DNA genotyping and mRNA expression. Gender- and age-matched mice of between 8–24 weeks of age were used for experiments. Similar results were obtained from male and female mice.</p></sec><sec id="s4-3"><title>Bone marrow-derived macrophage (BMDM) differentiation and cell culture</title><p>Macrophages were differentiated from primary mouse bone marrow from the femur and tibia using differentiation medium containing 30% L929-conditioned medium, 10% FBS, and pen-strep solution in low-glucose DMEM in 15-cm Petri dishes. Media were changed every three days, and cells were lifted, counted, and plated in final format in tissue culture plates on days 7–8 of differentiation. For experiments, primary macrophages were maintained in low glucose DMEM containing 10% FBS and pen-strep. For M1 activation, macrophages were primed with 10 ng/mL Ifn-γ for 10–12 hr and subsequently stimulated with 10 ng/mL of <italic>E. coli</italic> LPS at the start of each experiment. Macrophages with Ifn-γ priming but without LPS were used as the control for M1 activation.</p></sec><sec id="s4-4"><title>Peritoneal and splenic macrophage isolation and culture</title><p>For peritoneal macrophage isolation, mice aged 2–4 months were <italic>i.p.</italic> injected with 3 mL of 3% thioglycollate (Sigma-Aldrich, T9032). After 3 days, mice were euthanized, and peritoneal cells were recovered by lavage. For isolation of splenic macrophages, mice were euthanized and spleens were dissected and mashed in growth medium (high glucose DMEM with 10% FBS) and passed through a 70 μm strainer. Cells were pelleted and resuspended in red blood cell lysis buffer. Monocytes and lymphocytes were recovered using Ficoll-Paque Plus density gradient medium (GE Healthcare Life Sciences, 17144002) according to the manufacturer’s instructions, and suspension cells (lymphocytes) were washed away prior to experiments.</p></sec><sec id="s4-5"><title>LPS synchronization of Bmal1 expression</title><p>To synchronize <italic>Bmal1</italic> gene and protein expression with LPS (or LPS shock), BMDMs or mouse embryonic fibroblasts (MEFs) were given fresh culture medium with 2% FBS and 100 ng/mL LPS for 1 hr and then given fresh medium with 2% FBS without LPS. <italic>Bmal1</italic> expression was tracked following LPS removal. For M1 or LPS induction of <italic>Bmal1</italic> expression, cells were primed with or without 10 ng/mL Ifn-γ for 10–12 hr in DMEM, 10% FBS and subsequently stimulated with 10 ng/mL of LPS without changing the medium (time zero).</p></sec><sec id="s4-6"><title>Cell lines</title><p>MEFs were isolated from WT C57/BL6J mouse embryos and immortalized using the 3T3 protocol as previously described (<xref ref-type="bibr" rid="bib56">Xu, 2005</xref>). For experiments, immortalized MEFs were maintained in growth medium containing high glucose DMEM, 10% FBS. RAW264.7 mouse macrophages (TIB-71) and B16-F10 mouse melanoma cells (CRL-6475) were purchased from ATCC and experiments were conducted using early passages. Mycoplasma contamination was monitored using PCR-based methods. For generation of stable Bmal1-overexpressing RAW264.7 cells, the <italic>Bmal1</italic> coding sequence was cloned from mouse embryonic cDNA (forward primer: 5′ <named-content content-type="sequence">GGCGAATTCGCGGACCAGAGAATGGAC</named-content> 3′; reverse primer: 5′ <named-content content-type="sequence">GGGCTCGAGCTACAGCGGCCATGGCAA</named-content> 3′) and subcloned into the pBABE retroviral expression vector (Addgene, 1764). Retroviral vectors were transfected into Phoenix packaging cells, followed by collection of supernatants containing retroviruses. RAW264.7 macrophages were incubated with retroviral supernatants with 4 µg/mL polybrene, and infected cells were selected with 4 µg/mL puromycin. Control cells were transduced with the empty pBABE vector.</p></sec><sec id="s4-7"><title>Syngeneic tumor model and tumor measurement</title><p>Male and female WT and M-BKO mice aged 10–12 weeks were subcutaneously injected in the right flank with 300,000 B16-F10 mouse melanoma cells. For co-injection experiments, 500,000 B16-F10 cells were mixed with either 500,000 WT or M-BKO BMDMs (differentiation for 6 day) in the right and left flanks, respectively. Tumor dimensions were measured every two days by caliper after all mice had palpable tumors, and tumor volume was calculated as LxWxWx0.52 as previously described (<xref ref-type="bibr" rid="bib8">Colegio et al., 2014</xref>). For DMM treatment, mice were switched to a soft pellet, high fat diet (Bio-Serv, F3282) so that DMM could be mixed with the diet using a blender. The tumor growth rate was slower on high fat diet (<xref ref-type="fig" rid="fig7">Figure 7C</xref>) compared to normal chow (<xref ref-type="fig" rid="fig7">Figure 7A</xref>).</p></sec><sec id="s4-8"><title>RNA sequencing</title><p>RNA-seq was performed on RNA from three biological replicates per treatment. Sequencing and raw data processing were conducted at the Institute of Molecular Biology (IMB) Genomics Core and IMB Bioinformatics Service Core, respectively, at Academia Sinica (Taipei, Taiwan, ROC). In brief, RNA was quantified using the Quant-iT ribogreen RNA reagent (ThermoFisher, R11491), and RNA quality was determined using a Bioanalyzer 2100 (Agilent; RIN &gt; 8, OD 260/280 and OD 260/230 &gt; 1.8). RNA libraries were prepared using the TruSeq Stranded mRNA Library Preparation Kit (Illumina, RS-122–2101). Sequencing was analyzed with an Illumina NextSeq 500 instrument. Raw data were analyzed using the CLC Genomics Workbench. Raw sequencing reads were trimmed by removing adapter sequences, low-quality sequences (Phred quality score of &lt;20) and sequences &gt;25 bp in length. The trimmed reads were then mapped to the mouse genome assembly (mm10) from University of California, Santa Cruz, using the following parameters: mismatches = 2, minimum fraction length = 0.9, minimum fraction similarity = 0.9, and maximum hits per read = 5. Gene expression was determined by the number of transcripts per kilobase million. Functional annotation clustering of differentially regulated genes was done using DAVID (<ext-link ext-link-type="uri" xlink:href="https://david-d.ncifcrf.gov/">https://david-d.ncifcrf.gov/</ext-link>), and the interaction maps of transcriptional regulators that were induced or repressed by M1 activation that are shown in <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref> were generated using STRING (<ext-link ext-link-type="uri" xlink:href="https://string-db.org/">https://string-db.org/</ext-link>). Significantly changed genes were determined by p&lt;0.05 and FDR &lt;0.05. Data have been deposited in GEO under the accession number GSE148510.</p></sec><sec id="s4-9"><title>qPCR</title><p>Relative gene expression was determined by real-time qPCR with SYBR Green. The expression of the ribosomal subunit <italic>36b4</italic> (<italic>Rplp0</italic>) was used as an internal control to normalize expression data. Primer information is described in the 'Key resources table'.</p></sec><sec id="s4-10"><title>Western blot</title><p>Standard Tris-Glycine SDS-PAGEs were run and transferred to PVDF membranes by wet transfer. Membranes were incubated with primary antibodies in TBST buffer with 1% BSA overnight. ECL signal was imaged using a BioRad ChemiDoc XRS+ imaging system. The antibody for Bmal1 (sc365645) was from Santa Cruz. The antibody for Hif-1α (NB100-449) was from Novus Biologicals. The antibodies for β-tubulin (2146) and β-actin (4970) were from Cell Signaling Technology.</p></sec><sec id="s4-11"><title>Extracellular flux analyses</title><p>Extracellular flux experiments were done using a Seahorse XF24 analyzer (Agilent) and FluxPaks (Agilent, 100850–001). 200,000 BMDMs, splenic/peritoneal macrophages or RAW264.7 cells were seeded into Seahorse XF24 plates for extracellular flux experiments. Minimal DMEM (pH 7.4) without phenol red and containing energy substrates as indicated was used as the assay medium. 2% dialyzed FBS was added to media for experiments in which LPS was injected during the assay to enhance responsiveness to LPS. Assay measurements were normalized to total protein content.</p></sec><sec id="s4-12"><title>Glucose uptake assay</title><p>BMDMs were plated at a density of 1 million cells per well in 12-well plates and stimulated as indicated. Cells were then washed with Krebs-Ringer bicarbonate HEPES (KRBH) buffer and then given 400 μL with KRBH buffer loaded with 0.8 μCi/well [<sup>3</sup>H]−2-deoxyglucose (PerkinElmer, NET549A001MC) and 0.5 mM unlabeled 2-deoxyglucose and incubated at 37°C for 30 min. 10 μL of 1.5 mM Cytochalasin B (Cayman Chemical, 11328) was then added to stop glucose uptake. 400 μL of lysate was used to measure levels of [<sup>3</sup>H]−2-deoxyglucose by a scintillation counter, and the remaining lysate was used to measure total protein content for normalization.</p></sec><sec id="s4-13"><title>Measurement of lactic acid secretion</title><p>Lactic acid was measured in the supernatants of BMDMs using the Biovision Lactate Colorimetric Kit (K627) according to the manufacturer’s protocol. Readings were normalized to total cellular protein content.</p></sec><sec id="s4-14"><title>Mitochondrial isolation</title><p>Mitochondria were isolated from primary BMDMs by differential centrifugation. In brief, cells were resuspended in 500 μL of ice-cold mitochondrial isolation buffer consisting of 70 mM sucrose, 50 mM Tris, 50 mM KCl, 10 mM EDTA, and 0.2% fatty-acid free BSA (pH 7.2) and then extruded through 29-gauge syringes 20 times. Lysates were spun at 800 g to pellet nuclei, and supernatants were spun at 8000 g to isolate mitochondria. Pelleted mitochondria were washed once more with 500 μL of mitochondria isolation buffer. Total mitochondrial protein content was determined by BCA assay.</p></sec><sec id="s4-15"><title>ETC activity assays in isolated mitochondria</title><p>The activities of ETC complexes I–IV were measured in isolated mitochondria using colorimetric assays as previously described (<xref ref-type="bibr" rid="bib47">Spinazzi et al., 2012</xref>) with modifications. In brief, 15 μg of mitochondria were loaded per reaction for complexes III and IV, and 30 and 50 μg were used for complexes II and I, respectively. Complex I activity was determined by the decrease in absorbance at 340 nm corresponding to reduction of ubiquinone by electrons from NADH. Complex II activity was determined by the decrease in absorbance at 600 nm corresponding to reduction of decylubiquinone by electrons from succinate. Complex III activity was determined by the increase in absorbance at 550 nm corresponding to reduction of cytochrome C. Complex IV activity was determined by decrease in absorbance at 550 nm corresponding to oxidation of cytochrome C.</p></sec><sec id="s4-16"><title>Flow cytometry</title><p>For flow cytometry, BMDMs were seeded into low-attachment plates for the indicated treatments and resuspended by pipetting. Mitochondrial content in BMDMs was determined by flow cytometry of live cells stained with 100 μM Mitotracker Green FM (ThermoFisher, M7514) according to the manufacturer’s instructions.</p><p>For flow cytometry of tumor-infiltrating lymphocytes, cells were stimulated ex vivo with 20 ng/mL phorbol 12-myristate 13-acetate (PM), (Sigma-Aldrich, P8139) and 1 μg/mL ionomycin (Sigma-Aldrich, I0634) for 4 hr and co-treated with brefeldin A (Cell Signaling Technology, 9972) to inhibit cytokine release. Cells were stained with the fixable viability dye (eFluor 455uv [ThermoFisher, 65-868-14] or eFluor 506 [ThermoFisher, 65-0866-14]) for 20 min at 4°C in PBS, washed, and incubated with antibodies against the indicated surface antigens for 30 min at 4°C in fluorescence-activated cell sorting (FACS) buffer (2% FBS and 1 mM EDTA in PBS). Cells were then washed twice and fixed with 2% paraformaldehyde for 1 hr at 4°C, and resuspended and stored in FACS buffer prior to downstream analysis. Immediately before flow cytometric analysis, cells were permeabilized for intracellular staining using the Foxp3/Transcription factor staining buffer set (ThermoFisher, 00-5523-00) according to the manufacturer’s instructions. Of viable cells, CD8<sup>+</sup> T cells were identified as CD45<sup>+</sup>CD3<sup>+</sup>CD8a<sup>+</sup> cells and NK cells were identified by CD45<sup>+</sup> CD3<sup>–</sup> NK1.1<sup>+</sup> staining. To determine glucose uptake and mROS production by primary TAMs, live cells were stained with either 5 μM Mitosox Red (ThermoFisher, M36008) or 10 μM 2-NBDG (ThermoFisher, N13195) for 20 min in RPMI 1640 medium at 37°C, then washed and resuspended in FACS buffer for flow cytometry. F480<sup>+</sup> cells were gated from live CD45<sup>+</sup> cells to measure the mean fluorescent intensities of Mitosox or 2-NBDG. Antibodies for PerCp/Cy5.5-conjugated CD45 (103132), PE/Cy7-conjugated CD3e (100320), Alexa Fluor 700-conjugated CD8a (100730), APC-conjugated NK1.1 (108710) Alexa 488-conjugated F480 (123120) and APC-conjugated F480 (123115) were from Biolegend. The antibody for PE-conjugated Ifn-γ (12-7311-81) was from ThermoFisher Scientific.</p><p>To measure ROS production by isolated mitochondria, 15 μg of mitochondria were resuspended in 500 μL mitochondrial isolation buffer containing 5 μM MitoSox Red and 100 μM MitoTracker Green FM with or without 10 mM sodium succinate. Mitochondria were incubated for 20 min at room temperature, washed with isolation buffer, and resuspended for flow cytometry. Mitochondria were identified by side scatter and positive MitoTracker Green staining for measurement of mean MitoSox Red intensity per population.</p></sec><sec id="s4-17"><title>Steady-state metabolomics</title><p>Untargeted metabolomics analysis using GC-TOF mass spectrometry was conducted by the West Coast Metabolomics Center at UC Davis. In brief, 10 million cells were lifted, pelleted, and washed twice with PBS for each replicate. Cell lysates were homogenized by metal bead beating, and metabolites were extracted using 80% methanol. Following extraction, cell pellets were solubilized using Tris-HCl urea buffer (pH 8.0) containing 1% SDS to measure cellular protein content for each sample. All metabolite readings were normalized to total protein content.</p></sec><sec id="s4-18"><title>Collection of tumor-conditioned medium</title><p>Mice bearing subcutaneous B16-F10 tumors were sacrificed 20 days after injection with 500,000 cells. Tumors were dissected and weighed. Tumors were minced in growth medium containing 10% dialyzed FBS in high-glucose DMEM (5 mL per gram of tissue) and incubated at 37°C for 2 hr. Conditioned medium was collected and filtered through a 100 μm strainer followed by three spins at 1,000 rpm to pellet and remove residual cells and debris from the medium.</p></sec><sec id="s4-19"><title>Isolation of tumor-infiltrating immune cells</title><p>Subcutaneous mouse tumors were dissected, weighed, and then placed in six-well plates with growth medium (RPMI, 5% FBS) and minced. Minced tissues were combined into three groups per genotype, spun down in 50 mL conical tubes, and resuspended in 20 mL digestion buffer (0.5 mg/mL collagenase IV, 0.1 mg/mL DNase I in HBSS medium). Tumors were digested at 37°C with gentle shaking for 30 min and vortexed every 10 min. Contents were filtered through a 100 mm mesh, and cells were pelleted and resuspended in 45% percoll in 1X HBSS and 1X PBS. Cells were spun at 2000 rpm at 4°C with a swing bucket rotor for 20 min. The supernatant was aspirated, and the pellet was briefly resuspended in 5 mL ACK buffer to lyse red blood cells. Last, cells were pelleted and resuspended in growth medium for downstream applications.</p><p>To isolate F4/80<sup>+</sup> cells from tumors, tissues were homogenized and processed as above to collect tumor-infiltrating leukocytes. F4/80<sup>+</sup> cells were then isolated by positive selection using a rat anti-F4/80 antibody (Biolegend, 123120) and sheep anti-rat Dynabeads (ThermoFisher Scientific, 11035) according to the manufacturer’s instructions.</p></sec><sec id="s4-20"><title>Statistical analysis</title><p>All data are presented as mean ± SEM. GraphPad Prism 7 was used for statistical analyses. Two-tailed Student’s t test was used for comparisons of two parameters. Two-way ANOVA was used for multi-parameter analyses for time course comparisons. Cell-based experiments were performed with 3–5 biological replicates (cell culture replicates). For tumor volume, outliers were determined using a Rout test (p&lt;0.05), and outliers were omitted from downstream experiments.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We thank Drs D Cohen, D Sinclair, and P Weller for critical comments, A Yesian, L Dai, P Basak, R Chen, P Hu, and F Onal for technical help and the Academia Sinica (Taipei, Taiwan, ROC) for RNA sequencing/data analysis (IMB Genomics Core and Bioinformatics Service Core) and grant support (AS-106-TP-L08 [to NSL], AS-106-TP-L08-1 and AS-106-TP-L08-3). YHL was supported by funds from the Ministry of Science and Technology, Taiwan, ROC. This work was supported by grants from NIH (F31GM117854 to RKA; F31DK107256 to NHK; R01DK113791 and R21AI131659 to CHL) and the American Heart Association (16GRNT31460005 to CHL).</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con3"><p>Data curation, Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con4"><p>Validation, Investigation</p></fn><fn fn-type="con" id="con5"><p>Validation, Investigation</p></fn><fn fn-type="con" id="con6"><p>Resources</p></fn><fn fn-type="con" id="con7"><p>Resources</p></fn><fn fn-type="con" id="con8"><p>Resources</p></fn><fn fn-type="con" id="con9"><p>Formal analysis</p></fn><fn fn-type="con" id="con10"><p>Conceptualization, Supervision, Funding acquisition, Writing - original draft, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other" id="fn1"><p>Animal experimentation: All animal studies were approved by the Harvard Medical Area Standing Committee on Animal Research. IACUC protocol #IS00001011.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-54090-transrepform-v2.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>Raw RNA-seq data on GEO: accession number GSE148510. All analyzed RNA-seq and metabolite data are included in the manuscript and source data for Figure 3 and Figure. 5.</p><p>The following dataset was generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Alexander</surname><given-names>RK</given-names></name><name><surname>Lee</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>RNA-sequencing of Wild-type and Bmal1 KO M1 macrophages</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE148510">GSE148510</pub-id></element-citation></p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrejeva</surname> <given-names>G</given-names></name><name><surname>Rathmell</surname> <given-names>JC</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Similarities and distinctions of Cancer and immune metabolism in inflammation and tumors</article-title><source>Cell Metabolism</source><volume>26</volume><fpage>49</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2017.06.004</pub-id><pub-id pub-id-type="pmid">28683294</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arts</surname> <given-names>RJ</given-names></name><name><surname>Plantinga</surname> <given-names>TS</given-names></name><name><surname>Tuit</surname> <given-names>S</given-names></name><name><surname>Ulas</surname> <given-names>T</given-names></name><name><surname>Heinhuis</surname> <given-names>B</given-names></name><name><surname>Tesselaar</surname> <given-names>M</given-names></name><name><surname>Sloot</surname> <given-names>Y</given-names></name><name><surname>Adema</surname> <given-names>GJ</given-names></name><name><surname>Joosten</surname> <given-names>LA</given-names></name><name><surname>Smit</surname> <given-names>JW</given-names></name><name><surname>Netea</surname> <given-names>MG</given-names></name><name><surname>Schultze</surname> <given-names>JL</given-names></name><name><surname>Netea-Maier</surname> <given-names>RT</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Transcriptional and metabolic reprogramming induce an inflammatory phenotype in non-medullary thyroid carcinoma-induced macrophages</article-title><source>OncoImmunology</source><volume>5</volume><elocation-id>e1229725</elocation-id><pub-id pub-id-type="doi">10.1080/2162402X.2016.1229725</pub-id><pub-id pub-id-type="pmid">28123869</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bell</surname> <given-names>EL</given-names></name><name><surname>Klimova</surname> <given-names>TA</given-names></name><name><surname>Eisenbart</surname> <given-names>J</given-names></name><name><surname>Moraes</surname> <given-names>CT</given-names></name><name><surname>Murphy</surname> <given-names>MP</given-names></name><name><surname>Budinger</surname> <given-names>GR</given-names></name><name><surname>Chandel</surname> <given-names>NS</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The qo site of the mitochondrial complex III is required for the transduction of hypoxic signaling via reactive oxygen species production</article-title><source>Journal of Cell Biology</source><volume>177</volume><fpage>1029</fpage><lpage>1036</lpage><pub-id pub-id-type="doi">10.1083/jcb.200609074</pub-id><pub-id pub-id-type="pmid">17562787</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buck</surname> <given-names>MD</given-names></name><name><surname>Sowell</surname> <given-names>RT</given-names></name><name><surname>Kaech</surname> <given-names>SM</given-names></name><name><surname>Pearce</surname> <given-names>EL</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Metabolic instruction of immunity</article-title><source>Cell</source><volume>169</volume><fpage>570</fpage><lpage>586</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.04.004</pub-id><pub-id pub-id-type="pmid">28475890</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Canaple</surname> <given-names>L</given-names></name><name><surname>Rambaud</surname> <given-names>J</given-names></name><name><surname>Dkhissi-Benyahya</surname> <given-names>O</given-names></name><name><surname>Rayet</surname> <given-names>B</given-names></name><name><surname>Tan</surname> <given-names>NS</given-names></name><name><surname>Michalik</surname> <given-names>L</given-names></name><name><surname>Delaunay</surname> <given-names>F</given-names></name><name><surname>Wahli</surname> <given-names>W</given-names></name><name><surname>Laudet</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Reciprocal regulation of brain and muscle Arnt-like protein 1 and peroxisome proliferator-activated receptor alpha defines a novel positive feedback loop in the rodent liver circadian clock</article-title><source>Molecular Endocrinology</source><volume>20</volume><fpage>1715</fpage><lpage>1727</lpage><pub-id pub-id-type="doi">10.1210/me.2006-0052</pub-id><pub-id pub-id-type="pmid">16556735</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chouchani</surname> <given-names>ET</given-names></name><name><surname>Pell</surname> <given-names>VR</given-names></name><name><surname>Gaude</surname> <given-names>E</given-names></name><name><surname>Aksentijević</surname> <given-names>D</given-names></name><name><surname>Sundier</surname> <given-names>SY</given-names></name><name><surname>Robb</surname> <given-names>EL</given-names></name><name><surname>Logan</surname> <given-names>A</given-names></name><name><surname>Nadtochiy</surname> <given-names>SM</given-names></name><name><surname>Ord</surname> <given-names>ENJ</given-names></name><name><surname>Smith</surname> <given-names>AC</given-names></name><name><surname>Eyassu</surname> <given-names>F</given-names></name><name><surname>Shirley</surname> <given-names>R</given-names></name><name><surname>Hu</surname> <given-names>CH</given-names></name><name><surname>Dare</surname> <given-names>AJ</given-names></name><name><surname>James</surname> <given-names>AM</given-names></name><name><surname>Rogatti</surname> <given-names>S</given-names></name><name><surname>Hartley</surname> <given-names>RC</given-names></name><name><surname>Eaton</surname> <given-names>S</given-names></name><name><surname>Costa</surname> <given-names>ASH</given-names></name><name><surname>Brookes</surname> <given-names>PS</given-names></name><name><surname>Davidson</surname> <given-names>SM</given-names></name><name><surname>Duchen</surname> <given-names>MR</given-names></name><name><surname>Saeb-Parsy</surname> <given-names>K</given-names></name><name><surname>Shattock</surname> <given-names>MJ</given-names></name><name><surname>Robinson</surname> <given-names>AJ</given-names></name><name><surname>Work</surname> <given-names>LM</given-names></name><name><surname>Frezza</surname> <given-names>C</given-names></name><name><surname>Krieg</surname> <given-names>T</given-names></name><name><surname>Murphy</surname> <given-names>MP</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS</article-title><source>Nature</source><volume>515</volume><fpage>431</fpage><lpage>435</lpage><pub-id pub-id-type="doi">10.1038/nature13909</pub-id><pub-id pub-id-type="pmid">25383517</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christensen</surname> <given-names>HN</given-names></name><name><surname>Handlogten</surname> <given-names>ME</given-names></name><name><surname>Lam</surname> <given-names>I</given-names></name><name><surname>Tager</surname> <given-names>HS</given-names></name><name><surname>Zand</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="1969">1969</year><article-title>A bicyclic amino acid to improve discriminations among transport systems</article-title><source>The Journal of Biological Chemistry</source><volume>244</volume><fpage>1510</fpage><lpage>1520</lpage><pub-id pub-id-type="pmid">4886308</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colegio</surname> <given-names>OR</given-names></name><name><surname>Chu</surname> <given-names>NQ</given-names></name><name><surname>Szabo</surname> <given-names>AL</given-names></name><name><surname>Chu</surname> <given-names>T</given-names></name><name><surname>Rhebergen</surname> <given-names>AM</given-names></name><name><surname>Jairam</surname> <given-names>V</given-names></name><name><surname>Cyrus</surname> <given-names>N</given-names></name><name><surname>Brokowski</surname> <given-names>CE</given-names></name><name><surname>Eisenbarth</surname> <given-names>SC</given-names></name><name><surname>Phillips</surname> <given-names>GM</given-names></name><name><surname>Cline</surname> <given-names>GW</given-names></name><name><surname>Phillips</surname> <given-names>AJ</given-names></name><name><surname>Medzhitov</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Functional polarization of tumour-associated macrophages by tumour-derived lactic acid</article-title><source>Nature</source><volume>513</volume><fpage>559</fpage><lpage>563</lpage><pub-id pub-id-type="doi">10.1038/nature13490</pub-id><pub-id pub-id-type="pmid">25043024</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cramer</surname> <given-names>T</given-names></name><name><surname>Yamanishi</surname> <given-names>Y</given-names></name><name><surname>Clausen</surname> <given-names>BE</given-names></name><name><surname>Förster</surname> <given-names>I</given-names></name><name><surname>Pawlinski</surname> <given-names>R</given-names></name><name><surname>Mackman</surname> <given-names>N</given-names></name><name><surname>Haase</surname> <given-names>VH</given-names></name><name><surname>Jaenisch</surname> <given-names>R</given-names></name><name><surname>Corr</surname> <given-names>M</given-names></name><name><surname>Nizet</surname> <given-names>V</given-names></name><name><surname>Firestein</surname> <given-names>GS</given-names></name><name><surname>Gerber</surname> <given-names>HP</given-names></name><name><surname>Ferrara</surname> <given-names>N</given-names></name><name><surname>Johnson</surname> <given-names>RS</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>HIF-1alpha is essential for myeloid cell-mediated inflammation</article-title><source>Cell</source><volume>112</volume><fpage>645</fpage><lpage>657</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(03)00154-5</pub-id><pub-id pub-id-type="pmid">12628185</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dai</surname> <given-names>L</given-names></name><name><surname>Bhargava</surname> <given-names>P</given-names></name><name><surname>Stanya</surname> <given-names>KJ</given-names></name><name><surname>Alexander</surname> <given-names>RK</given-names></name><name><surname>Liou</surname> <given-names>YH</given-names></name><name><surname>Jacobi</surname> <given-names>D</given-names></name><name><surname>Knudsen</surname> <given-names>NH</given-names></name><name><surname>Hyde</surname> <given-names>A</given-names></name><name><surname>Gangl</surname> <given-names>MR</given-names></name><name><surname>Liu</surname> <given-names>S</given-names></name><name><surname>Lee</surname> <given-names>CH</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Macrophage alternative activation confers protection against lipotoxicity-induced cell death</article-title><source>Molecular Metabolism</source><volume>6</volume><fpage>1186</fpage><lpage>1197</lpage><pub-id pub-id-type="doi">10.1016/j.molmet.2017.08.001</pub-id><pub-id pub-id-type="pmid">29031719</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Damiola</surname> <given-names>F</given-names></name><name><surname>Le Minh</surname> <given-names>N</given-names></name><name><surname>Preitner</surname> <given-names>N</given-names></name><name><surname>Kornmann</surname> <given-names>B</given-names></name><name><surname>Fleury-Olela</surname> <given-names>F</given-names></name><name><surname>Schibler</surname> <given-names>U</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Restricted feeding uncouples circadian oscillators in peripheral tissues from the central pacemaker in the suprachiasmatic nucleus</article-title><source>Genes &amp; Development</source><volume>14</volume><fpage>2950</fpage><lpage>2961</lpage><pub-id pub-id-type="doi">10.1101/gad.183500</pub-id><pub-id pub-id-type="pmid">11114885</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doedens</surname> <given-names>AL</given-names></name><name><surname>Stockmann</surname> <given-names>C</given-names></name><name><surname>Rubinstein</surname> <given-names>MP</given-names></name><name><surname>Liao</surname> <given-names>D</given-names></name><name><surname>Zhang</surname> <given-names>N</given-names></name><name><surname>DeNardo</surname> <given-names>DG</given-names></name><name><surname>Coussens</surname> <given-names>LM</given-names></name><name><surname>Karin</surname> <given-names>M</given-names></name><name><surname>Goldrath</surname> <given-names>AW</given-names></name><name><surname>Johnson</surname> <given-names>RS</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Macrophage expression of hypoxia-inducible factor-1 alpha suppresses T-cell function and promotes tumor progression</article-title><source>Cancer Research</source><volume>70</volume><fpage>7465</fpage><lpage>7475</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-10-1439</pub-id><pub-id pub-id-type="pmid">20841473</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Early</surname> <given-names>JO</given-names></name><name><surname>Menon</surname> <given-names>D</given-names></name><name><surname>Wyse</surname> <given-names>CA</given-names></name><name><surname>Cervantes-Silva</surname> <given-names>MP</given-names></name><name><surname>Zaslona</surname> <given-names>Z</given-names></name><name><surname>Carroll</surname> <given-names>RG</given-names></name><name><surname>Palsson-McDermott</surname> <given-names>EM</given-names></name><name><surname>Angiari</surname> <given-names>S</given-names></name><name><surname>Ryan</surname> <given-names>DG</given-names></name><name><surname>Corcoran</surname> <given-names>SE</given-names></name><name><surname>Timmons</surname> <given-names>G</given-names></name><name><surname>Geiger</surname> <given-names>SS</given-names></name><name><surname>Fitzpatrick</surname> <given-names>DJ</given-names></name><name><surname>O'Connell</surname> <given-names>D</given-names></name><name><surname>Xavier</surname> <given-names>RJ</given-names></name><name><surname>Hokamp</surname> <given-names>K</given-names></name><name><surname>O'Neill</surname> <given-names>LAJ</given-names></name><name><surname>Curtis</surname> <given-names>AM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Circadian clock protein BMAL1 regulates IL-1β in macrophages via NRF2</article-title><source>PNAS</source><volume>115</volume><fpage>E8460</fpage><lpage>E8468</lpage><pub-id pub-id-type="doi">10.1073/pnas.1800431115</pub-id><pub-id pub-id-type="pmid">30127006</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fukuzumi</surname> <given-names>M</given-names></name><name><surname>Shinomiya</surname> <given-names>H</given-names></name><name><surname>Shimizu</surname> <given-names>Y</given-names></name><name><surname>Ohishi</surname> <given-names>K</given-names></name><name><surname>Utsumi</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Endotoxin-induced enhancement of glucose influx into murine peritoneal macrophages via GLUT1</article-title><source>Infection and Immunity</source><volume>64</volume><fpage>108</fpage><lpage>112</lpage><pub-id pub-id-type="doi">10.1128/IAI.64.1.108-112.1996</pub-id><pub-id pub-id-type="pmid">8557327</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ganeshan</surname> <given-names>K</given-names></name><name><surname>Chawla</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Metabolic regulation of immune responses</article-title><source>Annual Review of Immunology</source><volume>32</volume><fpage>609</fpage><lpage>634</lpage><pub-id pub-id-type="doi">10.1146/annurev-immunol-032713-120236</pub-id><pub-id pub-id-type="pmid">24655299</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geiger</surname> <given-names>R</given-names></name><name><surname>Rieckmann</surname> <given-names>JC</given-names></name><name><surname>Wolf</surname> <given-names>T</given-names></name><name><surname>Basso</surname> <given-names>C</given-names></name><name><surname>Feng</surname> <given-names>Y</given-names></name><name><surname>Fuhrer</surname> <given-names>T</given-names></name><name><surname>Kogadeeva</surname> <given-names>M</given-names></name><name><surname>Picotti</surname> <given-names>P</given-names></name><name><surname>Meissner</surname> <given-names>F</given-names></name><name><surname>Mann</surname> <given-names>M</given-names></name><name><surname>Zamboni</surname> <given-names>N</given-names></name><name><surname>Sallusto</surname> <given-names>F</given-names></name><name><surname>Lanzavecchia</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>L-Arginine modulates T cell metabolism and enhances survival and Anti-tumor activity</article-title><source>Cell</source><volume>167</volume><fpage>829</fpage><lpage>842</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.09.031</pub-id><pub-id pub-id-type="pmid">27745970</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grebhardt</surname> <given-names>S</given-names></name><name><surname>Veltkamp</surname> <given-names>C</given-names></name><name><surname>Ströbel</surname> <given-names>P</given-names></name><name><surname>Mayer</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Hypoxia and HIF-1 increase S100A8 and S100A9 expression in prostate Cancer</article-title><source>International Journal of Cancer</source><volume>131</volume><fpage>2785</fpage><lpage>2794</lpage><pub-id pub-id-type="doi">10.1002/ijc.27591</pub-id><pub-id pub-id-type="pmid">22505354</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hardin</surname> <given-names>PE</given-names></name><name><surname>Panda</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Circadian timekeeping and output mechanisms in animals</article-title><source>Current Opinion in Neurobiology</source><volume>23</volume><fpage>724</fpage><lpage>731</lpage><pub-id pub-id-type="doi">10.1016/j.conb.2013.02.018</pub-id><pub-id pub-id-type="pmid">23731779</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hotamisligil</surname> <given-names>GS</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Foundations of immunometabolism and implications for metabolic health and disease</article-title><source>Immunity</source><volume>47</volume><fpage>406</fpage><lpage>420</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2017.08.009</pub-id><pub-id pub-id-type="pmid">28930657</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>daW</given-names></name><name><surname>Sherman</surname> <given-names>BT</given-names></name><name><surname>Lempicki</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources</article-title><source>Nature Protocols</source><volume>4</volume><fpage>44</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1038/nprot.2008.211</pub-id><pub-id pub-id-type="pmid">19131956</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaakkola</surname> <given-names>P</given-names></name><name><surname>Mole</surname> <given-names>DR</given-names></name><name><surname>Tian</surname> <given-names>YM</given-names></name><name><surname>Wilson</surname> <given-names>MI</given-names></name><name><surname>Gielbert</surname> <given-names>J</given-names></name><name><surname>Gaskell</surname> <given-names>SJ</given-names></name><name><surname>von Kriegsheim</surname> <given-names>A</given-names></name><name><surname>Hebestreit</surname> <given-names>HF</given-names></name><name><surname>Mukherji</surname> <given-names>M</given-names></name><name><surname>Schofield</surname> <given-names>CJ</given-names></name><name><surname>Maxwell</surname> <given-names>PH</given-names></name><name><surname>Pugh</surname> <given-names>CW</given-names></name><name><surname>Ratcliffe</surname> <given-names>PJ</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation</article-title><source>Science</source><volume>292</volume><fpage>468</fpage><lpage>472</lpage><pub-id pub-id-type="doi">10.1126/science.1059796</pub-id><pub-id pub-id-type="pmid">11292861</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacobi</surname> <given-names>D</given-names></name><name><surname>Liu</surname> <given-names>S</given-names></name><name><surname>Burkewitz</surname> <given-names>K</given-names></name><name><surname>Kory</surname> <given-names>N</given-names></name><name><surname>Knudsen</surname> <given-names>NH</given-names></name><name><surname>Alexander</surname> <given-names>RK</given-names></name><name><surname>Unluturk</surname> <given-names>U</given-names></name><name><surname>Li</surname> <given-names>X</given-names></name><name><surname>Kong</surname> <given-names>X</given-names></name><name><surname>Hyde</surname> <given-names>AL</given-names></name><name><surname>Gangl</surname> <given-names>MR</given-names></name><name><surname>Mair</surname> <given-names>WB</given-names></name><name><surname>Lee</surname> <given-names>CH</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Hepatic Bmal1 regulates rhythmic mitochondrial dynamics and promotes metabolic fitness</article-title><source>Cell Metabolism</source><volume>22</volume><fpage>709</fpage><lpage>720</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2015.08.006</pub-id><pub-id pub-id-type="pmid">26365180</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname> <given-names>K</given-names></name><name><surname>Reilly</surname> <given-names>SM</given-names></name><name><surname>Karabacak</surname> <given-names>V</given-names></name><name><surname>Gangl</surname> <given-names>MR</given-names></name><name><surname>Fitzgerald</surname> <given-names>K</given-names></name><name><surname>Hatano</surname> <given-names>B</given-names></name><name><surname>Lee</surname> <given-names>CH</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Adipocyte-derived Th2 cytokines and myeloid PPARdelta regulate macrophage polarization and insulin sensitivity</article-title><source>Cell Metabolism</source><volume>7</volume><fpage>485</fpage><lpage>495</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2008.04.002</pub-id><pub-id pub-id-type="pmid">18522830</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lam</surname> <given-names>MT</given-names></name><name><surname>Cho</surname> <given-names>H</given-names></name><name><surname>Lesch</surname> <given-names>HP</given-names></name><name><surname>Gosselin</surname> <given-names>D</given-names></name><name><surname>Heinz</surname> <given-names>S</given-names></name><name><surname>Tanaka-Oishi</surname> <given-names>Y</given-names></name><name><surname>Benner</surname> <given-names>C</given-names></name><name><surname>Kaikkonen</surname> <given-names>MU</given-names></name><name><surname>Kim</surname> <given-names>AS</given-names></name><name><surname>Kosaka</surname> <given-names>M</given-names></name><name><surname>Lee</surname> <given-names>CY</given-names></name><name><surname>Watt</surname> <given-names>A</given-names></name><name><surname>Grossman</surname> <given-names>TR</given-names></name><name><surname>Rosenfeld</surname> <given-names>MG</given-names></name><name><surname>Evans</surname> <given-names>RM</given-names></name><name><surname>Glass</surname> <given-names>CK</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Rev-Erbs repress macrophage gene expression by inhibiting enhancer-directed transcription</article-title><source>Nature</source><volume>498</volume><fpage>511</fpage><lpage>515</lpage><pub-id pub-id-type="doi">10.1038/nature12209</pub-id><pub-id pub-id-type="pmid">23728303</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamas</surname> <given-names>B</given-names></name><name><surname>Vergnaud-Gauduchon</surname> <given-names>J</given-names></name><name><surname>Goncalves-Mendes</surname> <given-names>N</given-names></name><name><surname>Perche</surname> <given-names>O</given-names></name><name><surname>Rossary</surname> <given-names>A</given-names></name><name><surname>Vasson</surname> <given-names>MP</given-names></name><name><surname>Farges</surname> <given-names>MC</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Altered functions of natural killer cells in response to L-Arginine availability</article-title><source>Cellular Immunology</source><volume>280</volume><fpage>182</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1016/j.cellimm.2012.11.018</pub-id><pub-id pub-id-type="pmid">23399839</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lampropoulou</surname> <given-names>V</given-names></name><name><surname>Sergushichev</surname> <given-names>A</given-names></name><name><surname>Bambouskova</surname> <given-names>M</given-names></name><name><surname>Nair</surname> <given-names>S</given-names></name><name><surname>Vincent</surname> <given-names>EE</given-names></name><name><surname>Loginicheva</surname> <given-names>E</given-names></name><name><surname>Cervantes-Barragan</surname> <given-names>L</given-names></name><name><surname>Ma</surname> <given-names>X</given-names></name><name><surname>Huang</surname> <given-names>SC</given-names></name><name><surname>Griss</surname> <given-names>T</given-names></name><name><surname>Weinheimer</surname> <given-names>CJ</given-names></name><name><surname>Khader</surname> <given-names>S</given-names></name><name><surname>Randolph</surname> <given-names>GJ</given-names></name><name><surname>Pearce</surname> <given-names>EJ</given-names></name><name><surname>Jones</surname> <given-names>RG</given-names></name><name><surname>Diwan</surname> <given-names>A</given-names></name><name><surname>Diamond</surname> <given-names>MS</given-names></name><name><surname>Artyomov</surname> <given-names>MN</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Itaconate links inhibition of succinate dehydrogenase with macrophage metabolic remodeling and regulation of inflammation</article-title><source>Cell Metabolism</source><volume>24</volume><fpage>158</fpage><lpage>166</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2016.06.004</pub-id><pub-id pub-id-type="pmid">27374498</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>CH</given-names></name><name><surname>Kang</surname> <given-names>K</given-names></name><name><surname>Mehl</surname> <given-names>IR</given-names></name><name><surname>Nofsinger</surname> <given-names>R</given-names></name><name><surname>Alaynick</surname> <given-names>WA</given-names></name><name><surname>Chong</surname> <given-names>LW</given-names></name><name><surname>Rosenfeld</surname> <given-names>JM</given-names></name><name><surname>Evans</surname> <given-names>RM</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Peroxisome proliferator-activated receptor Delta promotes very low-density lipoprotein-derived fatty acid catabolism in the macrophage</article-title><source>PNAS</source><volume>103</volume><fpage>2434</fpage><lpage>2439</lpage><pub-id pub-id-type="doi">10.1073/pnas.0510815103</pub-id><pub-id pub-id-type="pmid">16467150</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>F</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Zeller</surname> <given-names>KI</given-names></name><name><surname>Potter</surname> <given-names>JJ</given-names></name><name><surname>Wonsey</surname> <given-names>DR</given-names></name><name><surname>O'Donnell</surname> <given-names>KA</given-names></name><name><surname>Kim</surname> <given-names>JW</given-names></name><name><surname>Yustein</surname> <given-names>JT</given-names></name><name><surname>Lee</surname> <given-names>LA</given-names></name><name><surname>Dang</surname> <given-names>CV</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis</article-title><source>Molecular and Cellular Biology</source><volume>25</volume><fpage>6225</fpage><lpage>6234</lpage><pub-id pub-id-type="doi">10.1128/MCB.25.14.6225-6234.2005</pub-id><pub-id pub-id-type="pmid">15988031</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>S</given-names></name><name><surname>Brown</surname> <given-names>JD</given-names></name><name><surname>Stanya</surname> <given-names>KJ</given-names></name><name><surname>Homan</surname> <given-names>E</given-names></name><name><surname>Leidl</surname> <given-names>M</given-names></name><name><surname>Inouye</surname> <given-names>K</given-names></name><name><surname>Bhargava</surname> <given-names>P</given-names></name><name><surname>Gangl</surname> <given-names>MR</given-names></name><name><surname>Dai</surname> <given-names>L</given-names></name><name><surname>Hatano</surname> <given-names>B</given-names></name><name><surname>Hotamisligil</surname> <given-names>GS</given-names></name><name><surname>Saghatelian</surname> <given-names>A</given-names></name><name><surname>Plutzky</surname> <given-names>J</given-names></name><name><surname>Lee</surname> <given-names>CH</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>A diurnal serum lipid integrates hepatic lipogenesis and peripheral fatty acid use</article-title><source>Nature</source><volume>502</volume><fpage>550</fpage><lpage>554</lpage><pub-id pub-id-type="doi">10.1038/nature12710</pub-id><pub-id pub-id-type="pmid">24153306</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>D</given-names></name><name><surname>Chang</surname> <given-names>C</given-names></name><name><surname>Lu</surname> <given-names>N</given-names></name><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Lu</surname> <given-names>Q</given-names></name><name><surname>Ren</surname> <given-names>X</given-names></name><name><surname>Ren</surname> <given-names>P</given-names></name><name><surname>Zhao</surname> <given-names>D</given-names></name><name><surname>Wang</surname> <given-names>L</given-names></name><name><surname>Zhu</surname> <given-names>Y</given-names></name><name><surname>He</surname> <given-names>F</given-names></name><name><surname>Tang</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Comprehensive proteomics analysis reveals metabolic reprogramming of Tumor-Associated macrophages stimulated by the tumor microenvironment</article-title><source>Journal of Proteome Research</source><volume>16</volume><fpage>288</fpage><lpage>297</lpage><pub-id pub-id-type="doi">10.1021/acs.jproteome.6b00604</pub-id><pub-id pub-id-type="pmid">27809537</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marpegán</surname> <given-names>L</given-names></name><name><surname>Bekinschtein</surname> <given-names>TA</given-names></name><name><surname>Costas</surname> <given-names>MA</given-names></name><name><surname>Golombek</surname> <given-names>DA</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Circadian responses to endotoxin treatment in mice</article-title><source>Journal of Neuroimmunology</source><volume>160</volume><fpage>102</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1016/j.jneuroim.2004.11.003</pub-id><pub-id pub-id-type="pmid">15710463</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masson</surname> <given-names>N</given-names></name><name><surname>Ratcliffe</surname> <given-names>PJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Hypoxia signaling pathways in Cancer metabolism: the importance of co-selecting interconnected physiological pathways</article-title><source>Cancer &amp; Metabolism</source><volume>2</volume><elocation-id>3</elocation-id><pub-id pub-id-type="doi">10.1186/2049-3002-2-3</pub-id><pub-id pub-id-type="pmid">24491179</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mills</surname> <given-names>EL</given-names></name><name><surname>Kelly</surname> <given-names>B</given-names></name><name><surname>Logan</surname> <given-names>A</given-names></name><name><surname>Costa</surname> <given-names>ASH</given-names></name><name><surname>Varma</surname> <given-names>M</given-names></name><name><surname>Bryant</surname> <given-names>CE</given-names></name><name><surname>Tourlomousis</surname> <given-names>P</given-names></name><name><surname>Däbritz</surname> <given-names>JHM</given-names></name><name><surname>Gottlieb</surname> <given-names>E</given-names></name><name><surname>Latorre</surname> <given-names>I</given-names></name><name><surname>Corr</surname> <given-names>SC</given-names></name><name><surname>McManus</surname> <given-names>G</given-names></name><name><surname>Ryan</surname> <given-names>D</given-names></name><name><surname>Jacobs</surname> <given-names>HT</given-names></name><name><surname>Szibor</surname> <given-names>M</given-names></name><name><surname>Xavier</surname> <given-names>RJ</given-names></name><name><surname>Braun</surname> <given-names>T</given-names></name><name><surname>Frezza</surname> <given-names>C</given-names></name><name><surname>Murphy</surname> <given-names>MP</given-names></name><name><surname>O'Neill</surname> <given-names>LA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Succinate dehydrogenase supports metabolic repurposing of mitochondria to drive inflammatory macrophages</article-title><source>Cell</source><volume>167</volume><fpage>457</fpage><lpage>470</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.08.064</pub-id><pub-id pub-id-type="pmid">27667687</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mills</surname> <given-names>EL</given-names></name><name><surname>Ryan</surname> <given-names>DG</given-names></name><name><surname>Prag</surname> <given-names>HA</given-names></name><name><surname>Dikovskaya</surname> <given-names>D</given-names></name><name><surname>Menon</surname> <given-names>D</given-names></name><name><surname>Zaslona</surname> <given-names>Z</given-names></name><name><surname>Jedrychowski</surname> <given-names>MP</given-names></name><name><surname>Costa</surname> <given-names>ASH</given-names></name><name><surname>Higgins</surname> <given-names>M</given-names></name><name><surname>Hams</surname> <given-names>E</given-names></name><name><surname>Szpyt</surname> <given-names>J</given-names></name><name><surname>Runtsch</surname> <given-names>MC</given-names></name><name><surname>King</surname> <given-names>MS</given-names></name><name><surname>McGouran</surname> <given-names>JF</given-names></name><name><surname>Fischer</surname> <given-names>R</given-names></name><name><surname>Kessler</surname> <given-names>BM</given-names></name><name><surname>McGettrick</surname> <given-names>AF</given-names></name><name><surname>Hughes</surname> <given-names>MM</given-names></name><name><surname>Carroll</surname> <given-names>RG</given-names></name><name><surname>Booty</surname> <given-names>LM</given-names></name><name><surname>Knatko</surname> <given-names>EV</given-names></name><name><surname>Meakin</surname> <given-names>PJ</given-names></name><name><surname>Ashford</surname> <given-names>MLJ</given-names></name><name><surname>Modis</surname> <given-names>LK</given-names></name><name><surname>Brunori</surname> <given-names>G</given-names></name><name><surname>Sévin</surname> <given-names>DC</given-names></name><name><surname>Fallon</surname> <given-names>PG</given-names></name><name><surname>Caldwell</surname> <given-names>ST</given-names></name><name><surname>Kunji</surname> <given-names>ERS</given-names></name><name><surname>Chouchani</surname> <given-names>ET</given-names></name><name><surname>Frezza</surname> <given-names>C</given-names></name><name><surname>Dinkova-Kostova</surname> <given-names>AT</given-names></name><name><surname>Hartley</surname> <given-names>RC</given-names></name><name><surname>Murphy</surname> <given-names>MP</given-names></name><name><surname>O'Neill</surname> <given-names>LA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1</article-title><source>Nature</source><volume>556</volume><fpage>113</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1038/nature25986</pub-id><pub-id pub-id-type="pmid">29590092</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname> <given-names>KD</given-names></name><name><surname>Fentress</surname> <given-names>SJ</given-names></name><name><surname>Qiu</surname> <given-names>Y</given-names></name><name><surname>Yun</surname> <given-names>K</given-names></name><name><surname>Cox</surname> <given-names>JS</given-names></name><name><surname>Chawla</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Circadian gene Bmal1 regulates diurnal oscillations of Ly6C(hi) inflammatory monocytes</article-title><source>Science</source><volume>341</volume><fpage>1483</fpage><lpage>1488</lpage><pub-id pub-id-type="doi">10.1126/science.1240636</pub-id><pub-id pub-id-type="pmid">23970558</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Callaghan</surname> <given-names>EK</given-names></name><name><surname>Anderson</surname> <given-names>ST</given-names></name><name><surname>Moynagh</surname> <given-names>PN</given-names></name><name><surname>Coogan</surname> <given-names>AN</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Long-lasting effects of Sepsis on circadian rhythms in the mouse</article-title><source>PLOS ONE</source><volume>7</volume><elocation-id>e47087</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0047087</pub-id><pub-id pub-id-type="pmid">23071720</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Neill</surname> <given-names>LA</given-names></name><name><surname>Kishton</surname> <given-names>RJ</given-names></name><name><surname>Rathmell</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>A guide to immunometabolism for immunologists</article-title><source>Nature Reviews Immunology</source><volume>16</volume><fpage>553</fpage><lpage>565</lpage><pub-id pub-id-type="doi">10.1038/nri.2016.70</pub-id><pub-id pub-id-type="pmid">27396447</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Odegaard</surname> <given-names>JI</given-names></name><name><surname>Ricardo-Gonzalez</surname> <given-names>RR</given-names></name><name><surname>Goforth</surname> <given-names>MH</given-names></name><name><surname>Morel</surname> <given-names>CR</given-names></name><name><surname>Subramanian</surname> <given-names>V</given-names></name><name><surname>Mukundan</surname> <given-names>L</given-names></name><name><surname>Red Eagle</surname> <given-names>A</given-names></name><name><surname>Vats</surname> <given-names>D</given-names></name><name><surname>Brombacher</surname> <given-names>F</given-names></name><name><surname>Ferrante</surname> <given-names>AW</given-names></name><name><surname>Chawla</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance</article-title><source>Nature</source><volume>447</volume><fpage>1116</fpage><lpage>1120</lpage><pub-id pub-id-type="doi">10.1038/nature05894</pub-id><pub-id pub-id-type="pmid">17515919</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papagiannakopoulos</surname> <given-names>T</given-names></name><name><surname>Bauer</surname> <given-names>MR</given-names></name><name><surname>Davidson</surname> <given-names>SM</given-names></name><name><surname>Heimann</surname> <given-names>M</given-names></name><name><surname>Subbaraj</surname> <given-names>L</given-names></name><name><surname>Bhutkar</surname> <given-names>A</given-names></name><name><surname>Bartlebaugh</surname> <given-names>J</given-names></name><name><surname>Vander Heiden</surname> <given-names>MG</given-names></name><name><surname>Jacks</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Circadian rhythm disruption promotes lung tumorigenesis</article-title><source>Cell Metabolism</source><volume>24</volume><fpage>324</fpage><lpage>331</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2016.07.001</pub-id><pub-id pub-id-type="pmid">27476975</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peek</surname> <given-names>CB</given-names></name><name><surname>Affinati</surname> <given-names>AH</given-names></name><name><surname>Ramsey</surname> <given-names>KM</given-names></name><name><surname>Kuo</surname> <given-names>HY</given-names></name><name><surname>Yu</surname> <given-names>W</given-names></name><name><surname>Sena</surname> <given-names>LA</given-names></name><name><surname>Ilkayeva</surname> <given-names>O</given-names></name><name><surname>Marcheva</surname> <given-names>B</given-names></name><name><surname>Kobayashi</surname> <given-names>Y</given-names></name><name><surname>Omura</surname> <given-names>C</given-names></name><name><surname>Levine</surname> <given-names>DC</given-names></name><name><surname>Bacsik</surname> <given-names>DJ</given-names></name><name><surname>Gius</surname> <given-names>D</given-names></name><name><surname>Newgard</surname> <given-names>CB</given-names></name><name><surname>Goetzman</surname> <given-names>E</given-names></name><name><surname>Chandel</surname> <given-names>NS</given-names></name><name><surname>Denu</surname> <given-names>JM</given-names></name><name><surname>Mrksich</surname> <given-names>M</given-names></name><name><surname>Bass</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Circadian clock NAD+ cycle drives mitochondrial oxidative metabolism in mice</article-title><source>Science</source><volume>342</volume><elocation-id>1243417</elocation-id><pub-id pub-id-type="doi">10.1126/science.1243417</pub-id><pub-id pub-id-type="pmid">24051248</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Penny</surname> <given-names>HL</given-names></name><name><surname>Sieow</surname> <given-names>JL</given-names></name><name><surname>Adriani</surname> <given-names>G</given-names></name><name><surname>Yeap</surname> <given-names>WH</given-names></name><name><surname>See Chi Ee</surname> <given-names>P</given-names></name><name><surname>San Luis</surname> <given-names>B</given-names></name><name><surname>Lee</surname> <given-names>B</given-names></name><name><surname>Lee</surname> <given-names>T</given-names></name><name><surname>Mak</surname> <given-names>SY</given-names></name><name><surname>Ho</surname> <given-names>YS</given-names></name><name><surname>Lam</surname> <given-names>KP</given-names></name><name><surname>Ong</surname> <given-names>CK</given-names></name><name><surname>Huang</surname> <given-names>RY</given-names></name><name><surname>Ginhoux</surname> <given-names>F</given-names></name><name><surname>Rotzschke</surname> <given-names>O</given-names></name><name><surname>Kamm</surname> <given-names>RD</given-names></name><name><surname>Wong</surname> <given-names>SC</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Warburg metabolism in tumor-conditioned macrophages promotes metastasis in human pancreatic ductal adenocarcinoma</article-title><source>OncoImmunology</source><volume>5</volume><elocation-id>e1191731</elocation-id><pub-id pub-id-type="doi">10.1080/2162402X.2016.1191731</pub-id><pub-id pub-id-type="pmid">27622062</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robb</surname> <given-names>EL</given-names></name><name><surname>Hall</surname> <given-names>AR</given-names></name><name><surname>Prime</surname> <given-names>TA</given-names></name><name><surname>Eaton</surname> <given-names>S</given-names></name><name><surname>Szibor</surname> <given-names>M</given-names></name><name><surname>Viscomi</surname> <given-names>C</given-names></name><name><surname>James</surname> <given-names>AM</given-names></name><name><surname>Murphy</surname> <given-names>MP</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Control of mitochondrial superoxide production by reverse electron transport at complex I</article-title><source>Journal of Biological Chemistry</source><volume>293</volume><fpage>9869</fpage><lpage>9879</lpage><pub-id pub-id-type="doi">10.1074/jbc.RA118.003647</pub-id><pub-id pub-id-type="pmid">29743240</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodríguez-Prados</surname> <given-names>JC</given-names></name><name><surname>Través</surname> <given-names>PG</given-names></name><name><surname>Cuenca</surname> <given-names>J</given-names></name><name><surname>Rico</surname> <given-names>D</given-names></name><name><surname>Aragonés</surname> <given-names>J</given-names></name><name><surname>Martín-Sanz</surname> <given-names>P</given-names></name><name><surname>Cascante</surname> <given-names>M</given-names></name><name><surname>Boscá</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation</article-title><source>The Journal of Immunology</source><volume>185</volume><fpage>605</fpage><lpage>614</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0901698</pub-id><pub-id pub-id-type="pmid">20498354</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Segawa</surname> <given-names>H</given-names></name><name><surname>Fukasawa</surname> <given-names>Y</given-names></name><name><surname>Miyamoto</surname> <given-names>K</given-names></name><name><surname>Takeda</surname> <given-names>E</given-names></name><name><surname>Endou</surname> <given-names>H</given-names></name><name><surname>Kanai</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Identification and functional characterization of a <sup>na+</sup>-independent neutral amino acid transporter with broad substrate selectivity</article-title><source>Journal of Biological Chemistry</source><volume>274</volume><fpage>19745</fpage><lpage>19751</lpage><pub-id pub-id-type="doi">10.1074/jbc.274.28.19745</pub-id><pub-id pub-id-type="pmid">10391916</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Semenza</surname> <given-names>GL</given-names></name><name><surname>Roth</surname> <given-names>PH</given-names></name><name><surname>Fang</surname> <given-names>HM</given-names></name><name><surname>Wang</surname> <given-names>GL</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1</article-title><source>The Journal of Biological Chemistry</source><volume>269</volume><fpage>23757</fpage><lpage>23763</lpage><pub-id pub-id-type="pmid">8089148</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinclair</surname> <given-names>LV</given-names></name><name><surname>Rolf</surname> <given-names>J</given-names></name><name><surname>Emslie</surname> <given-names>E</given-names></name><name><surname>Shi</surname> <given-names>YB</given-names></name><name><surname>Taylor</surname> <given-names>PM</given-names></name><name><surname>Cantrell</surname> <given-names>DA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation</article-title><source>Nature Immunology</source><volume>14</volume><fpage>500</fpage><lpage>508</lpage><pub-id pub-id-type="doi">10.1038/ni.2556</pub-id><pub-id pub-id-type="pmid">23525088</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spinazzi</surname> <given-names>M</given-names></name><name><surname>Casarin</surname> <given-names>A</given-names></name><name><surname>Pertegato</surname> <given-names>V</given-names></name><name><surname>Salviati</surname> <given-names>L</given-names></name><name><surname>Angelini</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Assessment of mitochondrial respiratory chain enzymatic activities on tissues and cultured cells</article-title><source>Nature Protocols</source><volume>7</volume><fpage>1235</fpage><lpage>1246</lpage><pub-id pub-id-type="doi">10.1038/nprot.2012.058</pub-id><pub-id pub-id-type="pmid">22653162</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steggerda</surname> <given-names>SM</given-names></name><name><surname>Bennett</surname> <given-names>MK</given-names></name><name><surname>Chen</surname> <given-names>J</given-names></name><name><surname>Emberley</surname> <given-names>E</given-names></name><name><surname>Huang</surname> <given-names>T</given-names></name><name><surname>Janes</surname> <given-names>JR</given-names></name><name><surname>Li</surname> <given-names>W</given-names></name><name><surname>MacKinnon</surname> <given-names>AL</given-names></name><name><surname>Makkouk</surname> <given-names>A</given-names></name><name><surname>Marguier</surname> <given-names>G</given-names></name><name><surname>Murray</surname> <given-names>PJ</given-names></name><name><surname>Neou</surname> <given-names>S</given-names></name><name><surname>Pan</surname> <given-names>A</given-names></name><name><surname>Parlati</surname> <given-names>F</given-names></name><name><surname>Rodriguez</surname> <given-names>MLM</given-names></name><name><surname>Van de Velde</surname> <given-names>LA</given-names></name><name><surname>Wang</surname> <given-names>T</given-names></name><name><surname>Works</surname> <given-names>M</given-names></name><name><surname>Zhang</surname> <given-names>J</given-names></name><name><surname>Zhang</surname> <given-names>W</given-names></name><name><surname>Gross</surname> <given-names>MI</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment</article-title><source>Journal for ImmunoTherapy of Cancer</source><volume>5</volume><elocation-id>101</elocation-id><pub-id pub-id-type="doi">10.1186/s40425-017-0308-4</pub-id><pub-id pub-id-type="pmid">29254508</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tamaru</surname> <given-names>T</given-names></name><name><surname>Isojima</surname> <given-names>Y</given-names></name><name><surname>van der Horst</surname> <given-names>GT</given-names></name><name><surname>Takei</surname> <given-names>K</given-names></name><name><surname>Nagai</surname> <given-names>K</given-names></name><name><surname>Takamatsu</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Nucleocytoplasmic shuttling and phosphorylation of BMAL1 are regulated by circadian clock in cultured fibroblasts</article-title><source>Genes to Cells</source><volume>8</volume><fpage>973</fpage><lpage>983</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2443.2003.00686.x</pub-id><pub-id pub-id-type="pmid">14750952</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tannahill</surname> <given-names>GM</given-names></name><name><surname>Curtis</surname> <given-names>AM</given-names></name><name><surname>Adamik</surname> <given-names>J</given-names></name><name><surname>Palsson-McDermott</surname> <given-names>EM</given-names></name><name><surname>McGettrick</surname> <given-names>AF</given-names></name><name><surname>Goel</surname> <given-names>G</given-names></name><name><surname>Frezza</surname> <given-names>C</given-names></name><name><surname>Bernard</surname> <given-names>NJ</given-names></name><name><surname>Kelly</surname> <given-names>B</given-names></name><name><surname>Foley</surname> <given-names>NH</given-names></name><name><surname>Zheng</surname> <given-names>L</given-names></name><name><surname>Gardet</surname> <given-names>A</given-names></name><name><surname>Tong</surname> <given-names>Z</given-names></name><name><surname>Jany</surname> <given-names>SS</given-names></name><name><surname>Corr</surname> <given-names>SC</given-names></name><name><surname>Haneklaus</surname> <given-names>M</given-names></name><name><surname>Caffrey</surname> <given-names>BE</given-names></name><name><surname>Pierce</surname> <given-names>K</given-names></name><name><surname>Walmsley</surname> <given-names>S</given-names></name><name><surname>Beasley</surname> <given-names>FC</given-names></name><name><surname>Cummins</surname> <given-names>E</given-names></name><name><surname>Nizet</surname> <given-names>V</given-names></name><name><surname>Whyte</surname> <given-names>M</given-names></name><name><surname>Taylor</surname> <given-names>CT</given-names></name><name><surname>Lin</surname> <given-names>H</given-names></name><name><surname>Masters</surname> <given-names>SL</given-names></name><name><surname>Gottlieb</surname> <given-names>E</given-names></name><name><surname>Kelly</surname> <given-names>VP</given-names></name><name><surname>Clish</surname> <given-names>C</given-names></name><name><surname>Auron</surname> <given-names>PE</given-names></name><name><surname>Xavier</surname> <given-names>RJ</given-names></name><name><surname>O'Neill</surname> <given-names>LA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Succinate is an inflammatory signal that induces IL-1β through HIF-1α</article-title><source>Nature</source><volume>496</volume><fpage>238</fpage><lpage>242</lpage><pub-id pub-id-type="doi">10.1038/nature11986</pub-id><pub-id pub-id-type="pmid">23535595</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname> <given-names>LW</given-names></name><name><surname>Ashcroft</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Exploring the molecular interface between hypoxia-inducible factor signalling and mitochondria</article-title><source>Cellular and Molecular Life Sciences</source><volume>76</volume><fpage>1759</fpage><lpage>1777</lpage><pub-id pub-id-type="doi">10.1007/s00018-019-03039-y</pub-id><pub-id pub-id-type="pmid">30767037</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsukishiro</surname> <given-names>T</given-names></name><name><surname>Shimizu</surname> <given-names>Y</given-names></name><name><surname>Higuchi</surname> <given-names>K</given-names></name><name><surname>Watanabe</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Effect of branched-chain amino acids on the composition and cytolytic activity of liver-associated lymphocytes in rats</article-title><source>Journal of Gastroenterology and Hepatology</source><volume>15</volume><fpage>849</fpage><lpage>859</lpage><pub-id pub-id-type="doi">10.1046/j.1440-1746.2000.02220.x</pub-id><pub-id pub-id-type="pmid">11022824</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>von Mering</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>STRING: known and predicted protein-protein associations, integrated and transferred across organisms</article-title><source>Nucleic Acids Research</source><volume>33</volume><fpage>D433</fpage><lpage>D437</lpage><pub-id pub-id-type="doi">10.1093/nar/gki005</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>West</surname> <given-names>AP</given-names></name><name><surname>Brodsky</surname> <given-names>IE</given-names></name><name><surname>Rahner</surname> <given-names>C</given-names></name><name><surname>Woo</surname> <given-names>DK</given-names></name><name><surname>Erdjument-Bromage</surname> <given-names>H</given-names></name><name><surname>Tempst</surname> <given-names>P</given-names></name><name><surname>Walsh</surname> <given-names>MC</given-names></name><name><surname>Choi</surname> <given-names>Y</given-names></name><name><surname>Shadel</surname> <given-names>GS</given-names></name><name><surname>Ghosh</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>TLR signalling augments macrophage bactericidal activity through mitochondrial ROS</article-title><source>Nature</source><volume>472</volume><fpage>476</fpage><lpage>480</lpage><pub-id pub-id-type="doi">10.1038/nature09973</pub-id><pub-id pub-id-type="pmid">21525932</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woldt</surname> <given-names>E</given-names></name><name><surname>Sebti</surname> <given-names>Y</given-names></name><name><surname>Solt</surname> <given-names>LA</given-names></name><name><surname>Duhem</surname> <given-names>C</given-names></name><name><surname>Lancel</surname> <given-names>S</given-names></name><name><surname>Eeckhoute</surname> <given-names>J</given-names></name><name><surname>Hesselink</surname> <given-names>MK</given-names></name><name><surname>Paquet</surname> <given-names>C</given-names></name><name><surname>Delhaye</surname> <given-names>S</given-names></name><name><surname>Shin</surname> <given-names>Y</given-names></name><name><surname>Kamenecka</surname> <given-names>TM</given-names></name><name><surname>Schaart</surname> <given-names>G</given-names></name><name><surname>Lefebvre</surname> <given-names>P</given-names></name><name><surname>Nevière</surname> <given-names>R</given-names></name><name><surname>Burris</surname> <given-names>TP</given-names></name><name><surname>Schrauwen</surname> <given-names>P</given-names></name><name><surname>Staels</surname> <given-names>B</given-names></name><name><surname>Duez</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Rev-erb-α modulates skeletal muscle oxidative capacity by regulating mitochondrial biogenesis and autophagy</article-title><source>Nature Medicine</source><volume>19</volume><fpage>1039</fpage><lpage>1046</lpage><pub-id pub-id-type="doi">10.1038/nm.3213</pub-id><pub-id pub-id-type="pmid">23852339</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Preparation, culture, and immortalization of mouse embryonic fibroblasts</article-title><source>Current Protocols in Molecular Biology</source><volume>70</volume><elocation-id>mb2801s70</elocation-id><pub-id pub-id-type="doi">10.1002/0471142727.mb2801s70</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>X</given-names></name><name><surname>Downes</surname> <given-names>M</given-names></name><name><surname>Yu</surname> <given-names>RT</given-names></name><name><surname>Bookout</surname> <given-names>AL</given-names></name><name><surname>He</surname> <given-names>W</given-names></name><name><surname>Straume</surname> <given-names>M</given-names></name><name><surname>Mangelsdorf</surname> <given-names>DJ</given-names></name><name><surname>Evans</surname> <given-names>RM</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Nuclear receptor expression links the circadian clock to metabolism</article-title><source>Cell</source><volume>126</volume><fpage>801</fpage><lpage>810</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2006.06.050</pub-id><pub-id pub-id-type="pmid">16923398</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>H</given-names></name><name><surname>Bosch-Marce</surname> <given-names>M</given-names></name><name><surname>Shimoda</surname> <given-names>LA</given-names></name><name><surname>Tan</surname> <given-names>YS</given-names></name><name><surname>Baek</surname> <given-names>JH</given-names></name><name><surname>Wesley</surname> <given-names>JB</given-names></name><name><surname>Gonzalez</surname> <given-names>FJ</given-names></name><name><surname>Semenza</surname> <given-names>GL</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia</article-title><source>Journal of Biological Chemistry</source><volume>283</volume><fpage>10892</fpage><lpage>10903</lpage><pub-id pub-id-type="doi">10.1074/jbc.M800102200</pub-id><pub-id pub-id-type="pmid">18281291</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.54090.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Rothlin</surname><given-names>Carla V</given-names></name><role>Reviewing Editor</role><aff><institution>Yale School of Medicine</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>The study reveals the importance of the function of the circadian clock, through BMAL1, for the appropriate activation of the inflammatory response in macrophages. As such, it advances our understanding on the coordination between mitochondrial metabolism and inflammatory cascade towards the most appropriate macrophage response.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Bmal1 integrates mitochondrial metabolism and macrophage activation&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by two peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Satyajit Rath as the Senior Editor. The reviewers have opted to remain anonymous.</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>Summary:</p><p>The manuscript reports a cell-autonomous role for the circadian clock gene <italic>Bmal</italic> in the regulation of macrophage effector functions. Specifically, the authors find that macrophages deficient in Bmal1 upregulate the glycolytic capacity at the expense of mitochondrial function upon M1-like stimulation in a Hif-1α dependent manner. They also extend their findings in an in vivo tumor model, wherein Bmal deficiency results in improved anti-tumor response. Overall, the manuscript was found to be well written, the experiments properly controlled for and the results described supported by the authors' conclusions.</p><p>Essential revisions:</p><p>1) The manuscript mostly focuses on the role of Bmal in the regulation of M1-like stimulation. As such, it remains unclear whether the findings apply specifically to the role of Bmal in regulating metabolic reprogramming solely upon macrophage activation or also to the modulation of mitochondria metabolism in basal conditions.</p><p>2) Related to the point raised above, there appears to be a disconnect between the kinetics of expression of different components upon M1 activation and the effects on mitochondria. For example, the initial identification of Bmal as a regulator of multiple transcriptional modules activated/repressed upon M1 activation is based on transcriptional profiling at a specific time point (8h after induction). Follow up studies reveal complex activation/repression kinetics and dependency on Bmal, however it is unclear how the different events relate to Bmal protein induction (which is shown to be peaking at 12h). In Figure 2 it is shown that mitochondrial content decreases as rapidly as 2h upon M1 induction when it is unknown whether Bmal induction/stabilization has already occurred. Moreover, the decrease is explained by an increase in mitophagy even though the increase in Bnip3 doesn't occur until 8h after activation. Downregulation of mitochondria biogenesis regulators PPARg and PPARd could contribute to the phenotype, but loss of Bmal seems to affect only their reactivation not the initial repression. Thus, it is unclear whether the authors interpret these results as Bmal induction in M1 activated macrophages being required for the long-term recovery of mitochondrial homeostasis or for the early decrease in mitochondrial function/content, in which case the mechanism is unclear.</p><p>3) The findings on tumor associated macrophages (TAMs) need to be extended. Specifically, do TAMs derived from tumors display a similar regulation of Bmal1-mitochondrial capacity and glucose utilization as bone marrow-derived macrophages exposed to tumor derived conditioned medium?</p><p>4) The data presented in Figure 1—figure supplement 1 indicate that the clock program downstream of Bmal is activated upon M1 induction. This raises a number of questions about the relationship between Bmal role in metabolic regulation and its well-known activity as a molecular clock. Discussing these findings in light of existing literature would be helpful for the audience to understand their possible implications in terms of circadian regulation of immunometabolism.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.54090.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) The manuscript mostly focuses on the role of Bmal in the regulation of M1-like stimulation. As such, it remains unclear whether the findings apply specifically to the role of Bmal in regulating metabolic reprogramming solely upon macrophage activation or also to the modulation of mitochondria metabolism in basal conditions.</p></disp-quote><p>As the reviewers might be aware of, macrophages exhibit a spectrum of activation states. For our basal condition, cells were withdrawn from the differentiation medium (with L929 conditioned medium) and changed to DMEM, 10% FBS for the subsequence experiments. In the original (and the revised) Figure 2E, we showed the ECAR was the same between WT and M-BKO macrophages at the basal/unstimulated state.</p><p>To specifically address this question, we have performed Mitostress tests and measured mitochondrial respiration (oxygen consumption rate, OCR) under the basal condition or with a two-hour serum shock (50% FBS) that is known to synchronize circadian clock/Bmal1 expression in cultured cells. As shown in revised Figure 2—figure supplement 1C, there was no significant difference in the OCR between WT and M-BKO macrophages, with or without serum shock. We could not rule out the possibility that in vivo, Bmal1 deficiency may affect macrophage mitochondrial metabolism in an unstimulated state when energy substrate availability changes between feeding and fasting states. It would appear that under the experimental condition, Bmal1- mediated mitochondrial metabolism is more important in M1-activated macrophages.</p><disp-quote content-type="editor-comment"><p>2) Related to the point raised above, there appears to be a disconnect between the kinetics of expression of different components upon M1 activation and the effects on mitochondria. For example, the initial identification of Bmal as a regulator of multiple transcriptional modules activated/repressed upon M1 activation is based on transcriptional profiling at a specific time point (8h after induction). Follow up studies reveal complex activation/repression kinetics and dependency on Bmal, however it is unclear how the different events relate to Bmal protein induction (which is shown to be peaking at 12h). In Figure 2 it is shown that mitochondrial content decreases as rapidly as 2h upon M1 induction when it is unknown whether Bmal induction/stabilization has already occurred. Moreover, the decrease is explained by an increase in mitophagy even though the increase in Bnip3 doesn't occur until 8h after activation.</p></disp-quote><p>We agree there is a discordance between the peak protein accumulation and functional outcomes, which might be partly due to the limitation in detection sensitivity of immunoblotting. For instance, Hif-1α protein accumulation was detectable at 4 hour and peaked at 8 hours following M1 activation (Figure 4A). However, Hif-1α dependent glucose uptake and lactate production were evident at 4 hours (Figure 3C and 3D and Figure 4—figure supplement 1B and 1C). Bmal1 protein has already accumulated at 4 hours (Figure 1A) and a higher Hif-1α protein level was observed in M-BKO macrophages at this time point (Figure 4A). We have included in <xref ref-type="fig" rid="respfig1">Author response image 1</xref> the lactate production result with the 2-hour time point for the review purpose. Lactate release was induced by M1 activation at 2 hours in WT macrophages, which was further up regulated in M-BKO macrophages. As such Bmal1 is likely to have functional importance at early time points after M1 activation.</p><fig id="respfig1"><label>Author response image 1.</label><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54090-resp-fig1-v2.tif"/></fig><p>We have conducted new Mitostress test to examine mitochondrial respiration in unstimulated, 2-hour M1 or 6-hour M1 activation. As shown in the revised Figure 2—figure supplement 1B, 2h M1 activation suppressed mainly the basal OCR, while 6h M1 affected both basal and maximum respiration in WT macrophages. The suppressed mitochondrial respiration was to a greater extent in M-BKO macrophages at both time points. The comparison and statistical analysis of the basal OCR is presented in the revised Figure 2B. While the 6hr effect could be partly explained by Bnip3-mediated mitophagy, the 2hr effect could not, as pointed out by the reviewers. In fact, Figure 2C showed that given the same amount of protein, mitochondria isolated by M1 activated M-BKO had lower ETC complex activities, suggesting that M-BKO impacted mitochondrial quality as well. We have moved the Bnip3 immunoblotting to Figure 2—figure supplement 1A and modified the description by stating that the reduced mitochondrial content was accompanied by elevated Bnip3 protein levels. Potential underlying mechanisms for the early phase effect is described below.</p><disp-quote content-type="editor-comment"><p>Downregulation of mitochondria biogenesis regulators PPARg and PPARd could contribute to the phenotype, but loss of Bmal seems to affect only their reactivation not the initial repression. Thus, it is unclear whether the authors interpret these results as Bmal induction in M1 activated macrophages being required for the long-term recovery of mitochondrial homeostasis or for the early decrease in mitochondrial function/content, in which case the mechanism is unclear.</p></disp-quote><p>As discussed in point 2.1, results in the revised Figure 2—figure supplement 1B (and Figure 2B) confirmed that M-BKO indeed affected mitochondrial respiration in the early phase of M1 activation. To assess the recovery phase, we conducted parallel Mitostress tests with either serum shock or “LPS shock” synchronization. The inclusion of serum shock served two purposes: the first was to examine whether Bmal1 gene deletion affected basal respiration, as discussed in point 1, and the second was to provide as a reference for potential effects from medium change at the recovery phase. For these experiments, macrophages were given a 2-h serum shock (DMEM, 50% FBS) or acute LPS treatment (DMEM, 2% FBS, which induced Bmal1 gene/protein expression shown in Figure 1C), washed and cultured in DEME, 10% FBS or DMEM, 2% FBS, respectively, for additional 24 hours before the Mitostress tests. The use of 2% FBS in the acute LPS treatment was to further reduce any potential serum effects on synchronization. As mentioned in point 1, there was no genotypic difference in OCR under serum shock synchronization (revised Figure 2—figure supplement 1C). By contrast, the basal OCR of M-BKO macrophages remained suppressed 24 hours following the acute LPS treatment, while the basal OCR was completely recovered in WT macrophages (revised Figure 2—figure supplement 1D). Collectively, these results suggest that Bmal1 gene deletion impacts macrophage mitochondrial respiration both during and at the recovery phase of M1 stimulation.</p><p>For the early stage effect, we think one of the plausible mechanisms is through modulation of Hif-1α activation, as discussed in point 2.1. Hif-1α-mediated glycolysis drives pyruvate away from TCA cycle and towards lactate production. Increased lactate production was observed in M-BKO macrophages at 2hr following M1 activation (see <xref ref-type="fig" rid="respfig1">Author response image 1</xref>). It could also be mediated by downstream pathways of the circadian regulatory network. Notably, the Nr1d1/Nr1d2 nuclear receptor family members have been shown to negatively regulate macrophage inflammatory gene expression (Lam et al., 2013). The induction of Nr1d2 by M1 was almost completely abolished in M-BKO macrophages (Figure 1D). In concert, the expression of <italic>Cx3cr1</italic>, a direct target suppressed by Nr1d1/Nr1d2 (Lamet al., 2013), was higher in M1 activated M-BKO macrophages, compared to WT cells (Figure 5—source data 1). This suppressive effect of Nr1d1/Nr1d2 may dampen the inflammatory damage to mitochondrial function at the initial stage of M1 activation. We have discussed these potential mechanisms in the revised Discussion section.</p><disp-quote content-type="editor-comment"><p>3) The findings on tumor associated macrophages (TAMs) need to be extended. Specifically, do TAMs derived from tumors display a similar regulation of Bmal1-mitochondrial capacity and glucose utilization as bone marrow-derived macrophages exposed to tumor derived conditioned medium?</p></disp-quote><p>We agree it’s important that the proposed mechanism could be demonstrated in TAMs derived from tumors. Unfortunately, it is technically challenging to obtain sufficient TAMs from mouse tumor models for functional assays, such as mitochondrial respiration and glucose utilization. Using flow cytometry, we were able to stain F4/80+ cells from tumor lysate with 2NBDG, a fluorescent glucose analog, and Mitosox red to assess glucose uptake and mROS levels, respectively. As showed in the revised Figure 6—figure supplement 1A-1C, M-BKO TAMs from primary tumors also exhibited increased glucose uptake and mROS production, compared to WT TAMs.</p><disp-quote content-type="editor-comment"><p>4) The data presented in Figure 1—figure supplement 1 indicate that the clock program downstream of Bmal is activated upon M1 induction. This raises a number of questions about the relationship between Bmal role in metabolic regulation and its well-known activity as a molecular clock. Discussing these findings in light of existing literature would be helpful for the audience to understand their possible implications in terms of circadian regulation of immunometabolism.</p></disp-quote><p>We agree with the reviewers that Bmal1 is best known for its role as a master circadian regulator and our RNA-seq data indicate the clock program downstream of Bmal1 is activated by M1 activation. Studies have shown that certain components of the molecular clock are capably of suppressing the expression of inflammatory genes, including Nr1d1/Nr1d2 nuclear receptor family members discussed in point 2.2. Bmal1 has also been shown to regulate diurnal monocyte trafficking that appears to play an important role in immune response against pathogens and in limiting inflammatory damage (Nguyen et al., 2013). We think that as a circadian regulator, Bmal1 could modulate inflammatory gene expression through downstream effectors, such as Nr1d1/Nr1d2. As a metabolic regulator, Bmal1-mediated energetic control may provide energy needed for diurnal monocyte trafficking/migration. In the context of infection or LPS/M1 activation, Bmal1 may regulate the timing of glycolytic to oxidative metabolism transition that dictates the extent of Hif-1α activation and the associated inflammatory response/damage. As suggested by the reviewers, we have incorporated these points into the second paragraph of the Discussion.</p></body></sub-article></article>